https://cohostpodcasting.com <![CDATA[Pharmacy Friends]]> en a7e2008d-1772-4408-a8b0-a948e4d01b39 Thu, 16 Jul 2026 16:13:46 -0400 Wed, 29 Jul 2026 15:28:15 -0400 https://www.primetherapeutics.com/ <![CDATA[Pharmacy Friends]]> https://files.cohostpodcasting.com/quill-file-prod/931fc1fd-ba83-4892-a012-b1d1ac97563e/shows/a7e2008d-1772-4408-a8b0-a948e4d01b39/cover-art/original_9aa1bbed4aab025750b7182dc17d2e5f.jpg https://www.primetherapeutics.com/ episodic false https://feeds.cohostpodcasting.com/0HdSIWdz digitalcommunication@primetherapeutics.com 1336ba00-814b-11f1-b279-01a13bd06ee1 1336ba00-814b-11f1-b279-01a13bd06ee1 <![CDATA[Human-centered pharmacy: Putting the care in healthcare]]> Learn how nurse-led care coordination supports members right after their specialty therapy starts. Learn how the compassionate experts at Prime help members understand their treatment, set expectations and get support when it’s needed. 


Tune in to hear how nurse-led coordination is reducing costs and improving care for the better, including:


  • Fewer early missteps through clear patient education
  • Better member experience through personalized support
  • Reduced urgent care and ER visits through early symptom management


Chapters

02:22 - Introduction to care management

05:35 - Care management availability

06:45 - Patient impact of care management

10:17 - Common conditions that care management teams help with

11:52 - Caregiver assistance

14:23 - Better patient outcomes, means stronger health systems

17:33 - The "why" behind care management is about compassion

18:41 - Closing

]]> Sat, 06 Jun 2026 16:14:02 -0400 https://www.primetherapeutics.com/ 20:58 Learn how nurse-led care coordination supports members right after their specialty therapy starts. Learn how the compassionate experts at Prime help members understand their treatment, set expectations and get support when it’s needed. 


Tune in to hear how nurse-led coordination is reducing costs and improving care for the better, including:


  • Fewer early missteps through clear patient education
  • Better member experience through personalized support
  • Reduced urgent care and ER visits through early symptom management


Chapters

02:22 - Introduction to care management

05:35 - Care management availability

06:45 - Patient impact of care management

10:17 - Common conditions that care management teams help with

11:52 - Caregiver assistance

14:23 - Better patient outcomes, means stronger health systems

17:33 - The "why" behind care management is about compassion

18:41 - Closing

]]> Learn how nurse-led care coordination supports members right after their specialty therapy starts. Learn how the compassionate experts at Prime help members understand their treatment, set expectations and get support when it’s needed. 


Tune in to hear how nurse-led coordination is reducing costs and improving care for the better, including:


  • Fewer early missteps through clear patient education
  • Better member experience through personalized support
  • Reduced urgent care and ER visits through early symptom management


Chapters

02:22 - Introduction to care management

05:35 - Care management availability

06:45 - Patient impact of care management

10:17 - Common conditions that care management teams help with

11:52 - Caregiver assistance

14:23 - Better patient outcomes, means stronger health systems

17:33 - The "why" behind care management is about compassion

18:41 - Closing

]]> false full <![CDATA[Accelerated drug approvals: The big questions facing payers]]> Dive into the latest episode of Pharmacy Friends for a discussion of the FDA Commissioner’s National Priority Voucher pilot. While accelerated approvals may improve access to innovative therapies, what could a compressed decision-making window mean for evidence review, affordability assessment and implementation planning?

 

Prime experts Angela Sutton and Bob Greer explore the important roles clinical confidence and operational readiness will play in making solid coverage decisions. Hear what they’re most focused on, including:

  • Managing drug spend
  • Assessing coverage strategies
  • Determining policy risk


00:00 Introduction

02:10 What's generating all the questions now?

04:35 FDA Hearing

05:50 Pro's and con's of accelerated drug approvals

11:05 Policy uncertainty and impact to payers

11:54 Impact of FDA leadership changes

12:24 Meeting the moment

15:26 Using data to make better decisions that need to be fast

18:39 What we would tell the acting FDA leadership that matters

23:15 Closing

]]> Sat, 06 Jun 2026 16:13:55 -0400 https://www.primetherapeutics.com/ 25:14 Dive into the latest episode of Pharmacy Friends for a discussion of the FDA Commissioner’s National Priority Voucher pilot. While accelerated approvals may improve access to innovative therapies, what could a compressed decision-making window mean for evidence review, affordability assessment and implementation planning?

 

Prime experts Angela Sutton and Bob Greer explore the important roles clinical confidence and operational readiness will play in making solid coverage decisions. Hear what they’re most focused on, including:

  • Managing drug spend
  • Assessing coverage strategies
  • Determining policy risk


00:00 Introduction

02:10 What's generating all the questions now?

04:35 FDA Hearing

05:50 Pro's and con's of accelerated drug approvals

11:05 Policy uncertainty and impact to payers

11:54 Impact of FDA leadership changes

12:24 Meeting the moment

15:26 Using data to make better decisions that need to be fast

18:39 What we would tell the acting FDA leadership that matters

23:15 Closing

]]> Dive into the latest episode of Pharmacy Friends for a discussion of the FDA Commissioner’s National Priority Voucher pilot. While accelerated approvals may improve access to innovative therapies, what could a compressed decision-making window mean for evidence review, affordability assessment and implementation planning?

 

Prime experts Angela Sutton and Bob Greer explore the important roles clinical confidence and operational readiness will play in making solid coverage decisions. Hear what they’re most focused on, including:

  • Managing drug spend
  • Assessing coverage strategies
  • Determining policy risk


00:00 Introduction

02:10 What's generating all the questions now?

04:35 FDA Hearing

05:50 Pro's and con's of accelerated drug approvals

11:05 Policy uncertainty and impact to payers

11:54 Impact of FDA leadership changes

12:24 Meeting the moment

15:26 Using data to make better decisions that need to be fast

18:39 What we would tell the acting FDA leadership that matters

23:15 Closing

]]> false full <![CDATA[On-the-road @ AMCP Annual 2026: Innovative research and expert insights drive breakthroughs in health outcomes]]> Recorded live in Nashville at AMCP Annual 2026, our latest Pharmacy Friends shares takeaways on how real-world medical and pharmacy data, pharmacist-led outreach, and benefit integration are shaping payer decision-making.

 

00:45 - Why real-time evidence matters

09:37 - High-touch pharmacist-to-prescriber outreach helps deliver hard-dollar savings.

23:51 – Rare disease insight and reinforcing the need for individualized management and payer case-management opportunities.

36:02 -- Why site of care in CAR-T and BiTE therapy matter

43:20 – Why mental health parity compliance in government programs matter now 

52:55-- Integration signal by highlighting the value of coordinated care.

These insights are foundational to how Prime delivers value to health care payers. Using evidence-driven expertise on how therapies are used, where gaps exist and which patients benefit most from additional support, Prime translates research into smarter clinical strategies and high-touch support for patients. 

 

Dive into the real stories, smart insights, and everyday moments that bring the world of pharmacy and everyday life together—one authentic conversation at a time.

]]> Tue, 21 Apr 2026 16:14:02 -0400 https://www.primetherapeutics.com/ 58:43 Recorded live in Nashville at AMCP Annual 2026, our latest Pharmacy Friends shares takeaways on how real-world medical and pharmacy data, pharmacist-led outreach, and benefit integration are shaping payer decision-making.

 

00:45 - Why real-time evidence matters

09:37 - High-touch pharmacist-to-prescriber outreach helps deliver hard-dollar savings.

23:51 – Rare disease insight and reinforcing the need for individualized management and payer case-management opportunities.

36:02 -- Why site of care in CAR-T and BiTE therapy matter

43:20 – Why mental health parity compliance in government programs matter now 

52:55-- Integration signal by highlighting the value of coordinated care.

These insights are foundational to how Prime delivers value to health care payers. Using evidence-driven expertise on how therapies are used, where gaps exist and which patients benefit most from additional support, Prime translates research into smarter clinical strategies and high-touch support for patients. 

 

Dive into the real stories, smart insights, and everyday moments that bring the world of pharmacy and everyday life together—one authentic conversation at a time.

]]> Recorded live in Nashville at AMCP Annual 2026, our latest Pharmacy Friends shares takeaways on how real-world medical and pharmacy data, pharmacist-led outreach, and benefit integration are shaping payer decision-making.

 

00:45 - Why real-time evidence matters

09:37 - High-touch pharmacist-to-prescriber outreach helps deliver hard-dollar savings.

23:51 – Rare disease insight and reinforcing the need for individualized management and payer case-management opportunities.

36:02 -- Why site of care in CAR-T and BiTE therapy matter

43:20 – Why mental health parity compliance in government programs matter now 

52:55-- Integration signal by highlighting the value of coordinated care.

These insights are foundational to how Prime delivers value to health care payers. Using evidence-driven expertise on how therapies are used, where gaps exist and which patients benefit most from additional support, Prime translates research into smarter clinical strategies and high-touch support for patients. 

 

Dive into the real stories, smart insights, and everyday moments that bring the world of pharmacy and everyday life together—one authentic conversation at a time.

]]> false full <![CDATA[Assemble the Standards: Making Quality Second Nature at Prime ]]> Discover how Prime brings together industry recognized accreditation frameworks—like URAC, ISO, and NCQA—to create a unified, reliable approach to patient safety and operational excellence. In this episode, we break down how quality standards become everyday practice through embedded processes, continuous improvement, internal audits, and real world examples that demonstrate measurable impact for clients, members, and partners.


00:20: Intro

03:12: Importance of quality operations

15:50: Pharmacy accreditations on the frontline

22:15: Preparing for an emergency

23:25: Being a trusted partner

28:56: What's next in the quality universe?

31:52: New & emerging accreditations to watch

33:50: Closing

]]> Thu, 29 Jan 2026 16:14:02 -0500 https://www.primetherapeutics.com/ 37:58 Discover how Prime brings together industry recognized accreditation frameworks—like URAC, ISO, and NCQA—to create a unified, reliable approach to patient safety and operational excellence. In this episode, we break down how quality standards become everyday practice through embedded processes, continuous improvement, internal audits, and real world examples that demonstrate measurable impact for clients, members, and partners.


00:20: Intro

03:12: Importance of quality operations

15:50: Pharmacy accreditations on the frontline

22:15: Preparing for an emergency

23:25: Being a trusted partner

28:56: What's next in the quality universe?

31:52: New & emerging accreditations to watch

33:50: Closing

]]> Discover how Prime brings together industry recognized accreditation frameworks—like URAC, ISO, and NCQA—to create a unified, reliable approach to patient safety and operational excellence. In this episode, we break down how quality standards become everyday practice through embedded processes, continuous improvement, internal audits, and real world examples that demonstrate measurable impact for clients, members, and partners.


00:20: Intro

03:12: Importance of quality operations

15:50: Pharmacy accreditations on the frontline

22:15: Preparing for an emergency

23:25: Being a trusted partner

28:56: What's next in the quality universe?

31:52: New & emerging accreditations to watch

33:50: Closing

]]> false full <![CDATA[Early-onset cancer: Screening, costs and what's next]]> Early-onset cancers are rising—and they’re forcing people to rethink cancer, screenings and care models.

What if cancer care strategy needs to start earlier—and last longer? This Pharmacy Friends conversation breaks down the rise in early-onset cancers and the practical implications for prevention, benefit design, and affordability.


00:00 Intro

02:30 Basics of cancer in younger people

07:52 Early onset cancer impact on health plans

11:14 Patient challenges and decision making

15:23 Impact on affordability

22:00 Importance of medical and pharmacy benefit integration

27:38 New ways of offering cancer care

30:41 Role that AI can play in patient care

33:26 Should health care adapt for best clinical outcomes

34:50 Being an advocate for the patient

38:49 Closing


Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> Thu, 29 Jan 2026 16:14:02 -0500 https://www.primetherapeutics.com/ 44:35 Early-onset cancers are rising—and they’re forcing people to rethink cancer, screenings and care models.

What if cancer care strategy needs to start earlier—and last longer? This Pharmacy Friends conversation breaks down the rise in early-onset cancers and the practical implications for prevention, benefit design, and affordability.


00:00 Intro

02:30 Basics of cancer in younger people

07:52 Early onset cancer impact on health plans

11:14 Patient challenges and decision making

15:23 Impact on affordability

22:00 Importance of medical and pharmacy benefit integration

27:38 New ways of offering cancer care

30:41 Role that AI can play in patient care

33:26 Should health care adapt for best clinical outcomes

34:50 Being an advocate for the patient

38:49 Closing


Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> Early-onset cancers are rising—and they’re forcing people to rethink cancer, screenings and care models.

What if cancer care strategy needs to start earlier—and last longer? This Pharmacy Friends conversation breaks down the rise in early-onset cancers and the practical implications for prevention, benefit design, and affordability.


00:00 Intro

02:30 Basics of cancer in younger people

07:52 Early onset cancer impact on health plans

11:14 Patient challenges and decision making

15:23 Impact on affordability

22:00 Importance of medical and pharmacy benefit integration

27:38 New ways of offering cancer care

30:41 Role that AI can play in patient care

33:26 Should health care adapt for best clinical outcomes

34:50 Being an advocate for the patient

38:49 Closing


Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> false full <![CDATA[Reimagining the Pipeline: Cell & Gene Therapy Decisions That Shape Care]]> During this episode of Pharmacy Friends you’ll hear about the rapidly evolving world of cell and gene therapy, highlighting its promise, complexity, and growing impact across the health care ecosystem. Learn about the foundational definitions, emerging clinical innovations, and the expanding pipeline of therapies expected to reach the market in the coming years. It also examines regulatory developments, forecasting approaches, financial considerations, and the human elements that shape patient and provider decision‑making. Through expert insights and real‑world examples, the conversation illustrates how Prime is helping stakeholders navigate this dynamic landscape while preparing for the transformative potential of next‑generation therapies.


Listen to the latest episode of the “Pharmacy Friends” podcast

Read the latest Cell & Gene Pipeline Outlook

Learn more about how Prime manages cell and gene therapies


In this episode:

03:46 What is Cell & Gene Therapy?

04:34 What is the Cell & Gene Therapy Pipeline?

08:13 Why pay attention to cell & gene therapies?

12:45: Collaboration with all stakeholders is important to get the right therapies to patients

20:35: Digging in new therapies that are on the horizon

22:56: Importance of the FDA commissioner's national priority voucher

25:52: What to consider when these therapies are an option

28:40: Is cost a barrier to these therapies?

31:41: 2026 cell and gene therapy outlook

36:18: Closing - books and fishing

]]> Wed, 21 Jan 2026 16:14:02 -0500 https://www.primetherapeutics.com/ 40:22 During this episode of Pharmacy Friends you’ll hear about the rapidly evolving world of cell and gene therapy, highlighting its promise, complexity, and growing impact across the health care ecosystem. Learn about the foundational definitions, emerging clinical innovations, and the expanding pipeline of therapies expected to reach the market in the coming years. It also examines regulatory developments, forecasting approaches, financial considerations, and the human elements that shape patient and provider decision‑making. Through expert insights and real‑world examples, the conversation illustrates how Prime is helping stakeholders navigate this dynamic landscape while preparing for the transformative potential of next‑generation therapies.


Listen to the latest episode of the “Pharmacy Friends” podcast

Read the latest Cell & Gene Pipeline Outlook

Learn more about how Prime manages cell and gene therapies


In this episode:

03:46 What is Cell & Gene Therapy?

04:34 What is the Cell & Gene Therapy Pipeline?

08:13 Why pay attention to cell & gene therapies?

12:45: Collaboration with all stakeholders is important to get the right therapies to patients

20:35: Digging in new therapies that are on the horizon

22:56: Importance of the FDA commissioner's national priority voucher

25:52: What to consider when these therapies are an option

28:40: Is cost a barrier to these therapies?

31:41: 2026 cell and gene therapy outlook

36:18: Closing - books and fishing

]]> During this episode of Pharmacy Friends you’ll hear about the rapidly evolving world of cell and gene therapy, highlighting its promise, complexity, and growing impact across the health care ecosystem. Learn about the foundational definitions, emerging clinical innovations, and the expanding pipeline of therapies expected to reach the market in the coming years. It also examines regulatory developments, forecasting approaches, financial considerations, and the human elements that shape patient and provider decision‑making. Through expert insights and real‑world examples, the conversation illustrates how Prime is helping stakeholders navigate this dynamic landscape while preparing for the transformative potential of next‑generation therapies.


Listen to the latest episode of the “Pharmacy Friends” podcast

Read the latest Cell & Gene Pipeline Outlook

Learn more about how Prime manages cell and gene therapies


In this episode:

03:46 What is Cell & Gene Therapy?

04:34 What is the Cell & Gene Therapy Pipeline?

08:13 Why pay attention to cell & gene therapies?

12:45: Collaboration with all stakeholders is important to get the right therapies to patients

20:35: Digging in new therapies that are on the horizon

22:56: Importance of the FDA commissioner's national priority voucher

25:52: What to consider when these therapies are an option

28:40: Is cost a barrier to these therapies?

31:41: 2026 cell and gene therapy outlook

36:18: Closing - books and fishing

]]> false full <![CDATA[Beyond the Needle: Why Oral GLP-1s Matter Now]]> Learn about the FDA’s new expedited approval process for oral GLP-1 medications—a breakthrough that could transform obesity care. Host Maryam Tabatabai and Carole Kerzic talk about these once-daily pills, and their potential for the similar benefits as injectables without needles or refrigeration. With potential approval coming soon, oral GLP-1s could expand access, impact adherence, and help reshape the weight-loss market. Staying informed is critical: these drugs not only aid weight management but also improve cardiometabolic health. Tune in to learn why understanding the latest developments matters for payers, clinicians, patients, and policymakers.


GLP-1 Pipeline Update: November 2025


00:00 Overview

00:49 Introduction to oral GLP-1s

02:43 Evidence from clinical trials

10:28 Big picture if FDA approves oral GLP-1s

14:08 Must know: Non-peptide vs peptide

15:45 More patient friendly formulation?

17:38 Market & timing for oral GLP-s 


Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> Wed, 10 Dec 2025 16:14:02 -0500 https://www.primetherapeutics.com/ 22:16 Learn about the FDA’s new expedited approval process for oral GLP-1 medications—a breakthrough that could transform obesity care. Host Maryam Tabatabai and Carole Kerzic talk about these once-daily pills, and their potential for the similar benefits as injectables without needles or refrigeration. With potential approval coming soon, oral GLP-1s could expand access, impact adherence, and help reshape the weight-loss market. Staying informed is critical: these drugs not only aid weight management but also improve cardiometabolic health. Tune in to learn why understanding the latest developments matters for payers, clinicians, patients, and policymakers.


GLP-1 Pipeline Update: November 2025


00:00 Overview

00:49 Introduction to oral GLP-1s

02:43 Evidence from clinical trials

10:28 Big picture if FDA approves oral GLP-1s

14:08 Must know: Non-peptide vs peptide

15:45 More patient friendly formulation?

17:38 Market & timing for oral GLP-s 


Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> Learn about the FDA’s new expedited approval process for oral GLP-1 medications—a breakthrough that could transform obesity care. Host Maryam Tabatabai and Carole Kerzic talk about these once-daily pills, and their potential for the similar benefits as injectables without needles or refrigeration. With potential approval coming soon, oral GLP-1s could expand access, impact adherence, and help reshape the weight-loss market. Staying informed is critical: these drugs not only aid weight management but also improve cardiometabolic health. Tune in to learn why understanding the latest developments matters for payers, clinicians, patients, and policymakers.


GLP-1 Pipeline Update: November 2025


00:00 Overview

00:49 Introduction to oral GLP-1s

02:43 Evidence from clinical trials

10:28 Big picture if FDA approves oral GLP-1s

14:08 Must know: Non-peptide vs peptide

15:45 More patient friendly formulation?

17:38 Market & timing for oral GLP-s 


Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> false full <![CDATA[Real-world evidence and innovation in managed care pharmacy: Insights from AMCP Nexus 2025]]> Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you’ll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care. 

 

Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime’s research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. 

Research topics covered:


-------------------------

Content in this podcast is for informational or educational purposes only.

The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> Tue, 28 Oct 2025 16:14:02 -0400 https://www.primetherapeutics.com/ 39:32 Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you’ll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care. 

 

Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime’s research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. 

Research topics covered:


-------------------------

Content in this podcast is for informational or educational purposes only.

The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you’ll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care. 

 

Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime’s research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. 

Research topics covered:


-------------------------

Content in this podcast is for informational or educational purposes only.

The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> false full <![CDATA[Signals & Solutions – GLP-1s in the data age]]> Unpacking signals emerging from claims, medical records, and patient-reported outcomes to shape the next wave of GLP-1 strategy.

Listen in and hear from industry experts who explore the evolving story of GLP-1 medications. Host Maryam Tabatabai and her guests discuss three years of GLP1 research data and examine why data is essential for clinical decision support, population health, and predictive analytics. Pat Gleason, David Lassen and Sarah Taylor address why stakeholders need to think about tackling the rising costs of weight management and GLP-1 access and why they believe sharing real-world insights is important so next generation pharmacy solutions can be built. Tune in as we reveal what the latest data shows and what’s next for GLP-1 research and innovation.

Learn more about developing a holistic GLP-1 strategy
Get the latest GLP-1 insights
Year-3 adherence and persistence data
The Skinny on GLP-1s: Part 1 | Part 2

]]> Wed, 15 Oct 2025 16:14:06 -0400 https://www.primetherapeutics.com/ 22:51 Unpacking signals emerging from claims, medical records, and patient-reported outcomes to shape the next wave of GLP-1 strategy.

Listen in and hear from industry experts who explore the evolving story of GLP-1 medications. Host Maryam Tabatabai and her guests discuss three years of GLP1 research data and examine why data is essential for clinical decision support, population health, and predictive analytics. Pat Gleason, David Lassen and Sarah Taylor address why stakeholders need to think about tackling the rising costs of weight management and GLP-1 access and why they believe sharing real-world insights is important so next generation pharmacy solutions can be built. Tune in as we reveal what the latest data shows and what’s next for GLP-1 research and innovation.

Learn more about developing a holistic GLP-1 strategy
Get the latest GLP-1 insights
Year-3 adherence and persistence data
The Skinny on GLP-1s: Part 1 | Part 2

]]> Unpacking signals emerging from claims, medical records, and patient-reported outcomes to shape the next wave of GLP-1 strategy.

Listen in and hear from industry experts who explore the evolving story of GLP-1 medications. Host Maryam Tabatabai and her guests discuss three years of GLP1 research data and examine why data is essential for clinical decision support, population health, and predictive analytics. Pat Gleason, David Lassen and Sarah Taylor address why stakeholders need to think about tackling the rising costs of weight management and GLP-1 access and why they believe sharing real-world insights is important so next generation pharmacy solutions can be built. Tune in as we reveal what the latest data shows and what’s next for GLP-1 research and innovation.

Learn more about developing a holistic GLP-1 strategy
Get the latest GLP-1 insights
Year-3 adherence and persistence data
The Skinny on GLP-1s: Part 1 | Part 2

]]> false full <![CDATA[On the Road at Specialty Summit: Powering Change]]> We were in Times Square for our second annual “On-the-Road” at Specialty Summit Pharmacy Friends episode. 


And this year we had a big presence in the big apple. Today, you get to hear from some of our brightest thought leaders who were there to share their insights. From the latest medical pharmacy trends to the importance of having a partner in developing a biosimilar strategy and finally what’s in the equation for creating innovative solutions to help people get their medicine plus so much more.


Tune-in and subscribe to our podcast to learn about the latest health care and pharmacy trends.

 

Guests include:

(00:39) Jordan Almazan, Senior Director, Clinical Strategy & Specialty Solutions

(11:40) Steve Cutts, SVP, Specialty and Clinical Solutions

(31:47) George Van Antwerp, SVP, Product Innovation

(43:07) Dinesh Kandanchatha, SVP, Chief Information and Technology Officer
(01:00:25) Roxanne Schwans, SVP, Supply Chain

(01:08:12) Brian MacDonald, Senior Director, Clinical Strategy & Programs

(01:21:41) David Root, VP, Government Affairs AND

Caitlin Berry, Senior Principal, Government Affairs Policy Advisor

]]> Mon, 22 Sep 2025 16:14:06 -0400 https://www.primetherapeutics.com/ 1:33:53 We were in Times Square for our second annual “On-the-Road” at Specialty Summit Pharmacy Friends episode. 


And this year we had a big presence in the big apple. Today, you get to hear from some of our brightest thought leaders who were there to share their insights. From the latest medical pharmacy trends to the importance of having a partner in developing a biosimilar strategy and finally what’s in the equation for creating innovative solutions to help people get their medicine plus so much more.


Tune-in and subscribe to our podcast to learn about the latest health care and pharmacy trends.

 

Guests include:

(00:39) Jordan Almazan, Senior Director, Clinical Strategy & Specialty Solutions

(11:40) Steve Cutts, SVP, Specialty and Clinical Solutions

(31:47) George Van Antwerp, SVP, Product Innovation

(43:07) Dinesh Kandanchatha, SVP, Chief Information and Technology Officer
(01:00:25) Roxanne Schwans, SVP, Supply Chain

(01:08:12) Brian MacDonald, Senior Director, Clinical Strategy & Programs

(01:21:41) David Root, VP, Government Affairs AND

Caitlin Berry, Senior Principal, Government Affairs Policy Advisor

]]> We were in Times Square for our second annual “On-the-Road” at Specialty Summit Pharmacy Friends episode. 


And this year we had a big presence in the big apple. Today, you get to hear from some of our brightest thought leaders who were there to share their insights. From the latest medical pharmacy trends to the importance of having a partner in developing a biosimilar strategy and finally what’s in the equation for creating innovative solutions to help people get their medicine plus so much more.


Tune-in and subscribe to our podcast to learn about the latest health care and pharmacy trends.

 

Guests include:

(00:39) Jordan Almazan, Senior Director, Clinical Strategy & Specialty Solutions

(11:40) Steve Cutts, SVP, Specialty and Clinical Solutions

(31:47) George Van Antwerp, SVP, Product Innovation

(43:07) Dinesh Kandanchatha, SVP, Chief Information and Technology Officer
(01:00:25) Roxanne Schwans, SVP, Supply Chain

(01:08:12) Brian MacDonald, Senior Director, Clinical Strategy & Programs

(01:21:41) David Root, VP, Government Affairs AND

Caitlin Berry, Senior Principal, Government Affairs Policy Advisor

]]> false full <![CDATA[A New Era in Liver Health: GLP-1s and the MASH Breakthrough]]> In this episode, our host Maryam Tabatabai is joined by three guests Olivia Pane, PharmD; Dr. Edmundo Rodriguez Frias; and Katie Lockhart, who unpack insights from Prime Therapeutics’ latest clinical report that dives into the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH. MASH is a silent but serious liver condition affecting over 22 million Americans, with numbers projected to rise sharply by 2030.


Listeners learn about the latest major development in liver health treatment: the FDA approval of Novo Nordisk’s semaglutide – Wegovy -- as the first GLP-1 drug indicated for MASH. We explore how this development may revolutionize care and could offer a more affordable alternative to treating this condition.

The Evolution of GLP-1s
www.primetherapeutics.com
All Pharmacy Friends episodes

Metabolic dysfunction-associated steatohepatitis (MASH) – A new era in liver health


The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice

]]> Wed, 20 Aug 2025 16:14:06 -0400 https://www.primetherapeutics.com/ 12:13 In this episode, our host Maryam Tabatabai is joined by three guests Olivia Pane, PharmD; Dr. Edmundo Rodriguez Frias; and Katie Lockhart, who unpack insights from Prime Therapeutics’ latest clinical report that dives into the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH. MASH is a silent but serious liver condition affecting over 22 million Americans, with numbers projected to rise sharply by 2030.


Listeners learn about the latest major development in liver health treatment: the FDA approval of Novo Nordisk’s semaglutide – Wegovy -- as the first GLP-1 drug indicated for MASH. We explore how this development may revolutionize care and could offer a more affordable alternative to treating this condition.

The Evolution of GLP-1s
www.primetherapeutics.com
All Pharmacy Friends episodes

Metabolic dysfunction-associated steatohepatitis (MASH) – A new era in liver health


The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice

]]> In this episode, our host Maryam Tabatabai is joined by three guests Olivia Pane, PharmD; Dr. Edmundo Rodriguez Frias; and Katie Lockhart, who unpack insights from Prime Therapeutics’ latest clinical report that dives into the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH. MASH is a silent but serious liver condition affecting over 22 million Americans, with numbers projected to rise sharply by 2030.


Listeners learn about the latest major development in liver health treatment: the FDA approval of Novo Nordisk’s semaglutide – Wegovy -- as the first GLP-1 drug indicated for MASH. We explore how this development may revolutionize care and could offer a more affordable alternative to treating this condition.

The Evolution of GLP-1s
www.primetherapeutics.com
All Pharmacy Friends episodes

Metabolic dysfunction-associated steatohepatitis (MASH) – A new era in liver health


The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice

]]> false full <![CDATA[Culture brings purpose to life]]> Culture isn’t just a vibe — it’s a strategy. In this Pharmacy Friends episode, Prime's Erin Feigal (CHRO) and Jeff Kaczrowski (Director of Talent Acquisition) join host Laura Spitzack to explore how culture sparks innovation, drives engagement, and delivers real business results and why ignoring the idea of culture is like ignoring gravity.


From cultural commitments to leadership styles, hear how Prime’s 7,000+ employees band together to  deliver results, innovate for growth, win together and do what’s right. 


Whether you're leading a team or just trying to survive the next all-hands, tune in for sharp insights and how bold ideas—from mild to wild—prove culture is the ultimate business accelerator.


More about Prime's culture

Apply for a job at Prime

www.primetherapeutics.com

]]> Wed, 13 Aug 2025 16:14:06 -0400 https://www.primetherapeutics.com/ 21:01 Culture isn’t just a vibe — it’s a strategy. In this Pharmacy Friends episode, Prime's Erin Feigal (CHRO) and Jeff Kaczrowski (Director of Talent Acquisition) join host Laura Spitzack to explore how culture sparks innovation, drives engagement, and delivers real business results and why ignoring the idea of culture is like ignoring gravity.


From cultural commitments to leadership styles, hear how Prime’s 7,000+ employees band together to  deliver results, innovate for growth, win together and do what’s right. 


Whether you're leading a team or just trying to survive the next all-hands, tune in for sharp insights and how bold ideas—from mild to wild—prove culture is the ultimate business accelerator.


More about Prime's culture

Apply for a job at Prime

www.primetherapeutics.com

]]> Culture isn’t just a vibe — it’s a strategy. In this Pharmacy Friends episode, Prime's Erin Feigal (CHRO) and Jeff Kaczrowski (Director of Talent Acquisition) join host Laura Spitzack to explore how culture sparks innovation, drives engagement, and delivers real business results and why ignoring the idea of culture is like ignoring gravity.


From cultural commitments to leadership styles, hear how Prime’s 7,000+ employees band together to  deliver results, innovate for growth, win together and do what’s right. 


Whether you're leading a team or just trying to survive the next all-hands, tune in for sharp insights and how bold ideas—from mild to wild—prove culture is the ultimate business accelerator.


More about Prime's culture

Apply for a job at Prime

www.primetherapeutics.com

]]> false full <![CDATA[15 years of medical pharmacy expertise & trends]]> Health care is constantly evolving, especially in the realm of medical pharmacy. Prime Therapeutics (Prime) has been tracking that evolution for 15 years through its annual Medical Pharmacy Trend Report, where Prime experts examine trends, analyze data and share drug forecasts to help health plans and health care leaders make the best prescribing and coverage decisions. 

  

In the most recent episode of the Pharmacy Friends podcast, host Maryam Tabatabai, PharmD, vice president of clinical information, sat down with three leading experts — Kristen Reimers, senior vice president of specialty clinical solutions; Lisa Polakowski, director of the Medical Pharmacy Trend Report; and Ben Messerli, actuarial manager — to reflect on the history and future of this cornerstone report.


Stay tuned for the release of the Medical Pharmacy Trend Report this fall.


Want to be included in next year's research or need a printed version of of the report? Send us an email.


Follow us on our website and social channels.

https://www.primetherapeutics.com

Newsroom

 LinkedIn



"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.


Other ways to listen:

Amazon Music | Apple | Spotify

]]> Tue, 05 Aug 2025 16:14:06 -0400 https://www.primetherapeutics.com/ 27:17 Health care is constantly evolving, especially in the realm of medical pharmacy. Prime Therapeutics (Prime) has been tracking that evolution for 15 years through its annual Medical Pharmacy Trend Report, where Prime experts examine trends, analyze data and share drug forecasts to help health plans and health care leaders make the best prescribing and coverage decisions. 

  

In the most recent episode of the Pharmacy Friends podcast, host Maryam Tabatabai, PharmD, vice president of clinical information, sat down with three leading experts — Kristen Reimers, senior vice president of specialty clinical solutions; Lisa Polakowski, director of the Medical Pharmacy Trend Report; and Ben Messerli, actuarial manager — to reflect on the history and future of this cornerstone report.


Stay tuned for the release of the Medical Pharmacy Trend Report this fall.


Want to be included in next year's research or need a printed version of of the report? Send us an email.


Follow us on our website and social channels.

https://www.primetherapeutics.com

Newsroom

 LinkedIn



"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.


Other ways to listen:

Amazon Music | Apple | Spotify

]]> Health care is constantly evolving, especially in the realm of medical pharmacy. Prime Therapeutics (Prime) has been tracking that evolution for 15 years through its annual Medical Pharmacy Trend Report, where Prime experts examine trends, analyze data and share drug forecasts to help health plans and health care leaders make the best prescribing and coverage decisions. 

  

In the most recent episode of the Pharmacy Friends podcast, host Maryam Tabatabai, PharmD, vice president of clinical information, sat down with three leading experts — Kristen Reimers, senior vice president of specialty clinical solutions; Lisa Polakowski, director of the Medical Pharmacy Trend Report; and Ben Messerli, actuarial manager — to reflect on the history and future of this cornerstone report.


Stay tuned for the release of the Medical Pharmacy Trend Report this fall.


Want to be included in next year's research or need a printed version of of the report? Send us an email.


Follow us on our website and social channels.

https://www.primetherapeutics.com

Newsroom

 LinkedIn



"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.


Other ways to listen:

Amazon Music | Apple | Spotify

]]> false full <![CDATA[A look at next-gen oncology]]> In this episode, you’ll hear about the latest developments in tailoring cancer treatments to individual patients using Precision Oncology.  

Two thought leaders, Simone Ndujiuba, a Clinical Oncology Pharmacist at Prime Therapeutics, and Karan Cushman, Head of Brand Experience and host of The Precision Medicine Podcast for Trapelo Health, discuss real-world research that is paving the way for Prime and our partners to help providers reduce turnaround times so patients can start treatment as soon as possible.  Join your host Maryam Tabatabai as they dig into this evolving topic of precision oncology. 

www.primetherapeuitics.com 


⁠Chapters⁠

Defining precision medicine (08:50)

Evaluating real-world operational process of biomarker testing (14:36)

Turnaround times are crucial (17:40)

A patients view into the importance of time (24:39)

Technology and process aid in time and process (29:30)

Helping bridge knowledge gaps for providers and payers (33:55) 

The focus is on Precision Oncology right now (37:00)

Precision medicine in other disease categories (40:09)

Future of precision oncology is bright (42:07)

 

References 

  • Singh, B.P., et al. (2019). Molecular profiling (MP) for malignancies: Knowledge gaps and variable practice patterns among United States oncologists (Onc). 
    • American Society of Clinical Oncology. https://meetings. asco.org/abstracts-presentations/173392 
  • Evangelist, M.C., et al. (2023). Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study. Journal of Clinical Oncology, 41(Supplement 16). https://doi.org/10.1200/JCO.2023.41.16_suppl.9109. 
  • Ossowski, S., et al. (2022). Improving time to molecular testing results in patients with newly diagnosed, metastatic non-small cell lung cancer. Journal of Clinical Oncology, 18(11). https://doi.org/10.1200/OP.22.00260 
  • Naithani N, Atal AT, Tilak TVSVGK, et al. Precision medicine: Uses and challenges. Med J Armed Forces India. 2021 Jul;77(3):258-265. doi: 10.1016/j.mjafi.2021.06.020.  
  • Jørgensen JT. Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy. Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054.  
  • MedlinePlus. What is genetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/genetics/understanding/testing/genetictesting/. 
  • MedlinePlus. What is pharmacogenetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/lab-tests/pharmacogenetic-tests/#:~:text=Pharmacogenetics%20(also%20called%20pharmacogenomics)%20is,your%20height%20and%20eye%20color.  
  • Riely GJ, Wood DE, Aisner DL, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: non-small cell lung cancer, V3.2005. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.  
  • Benson AB, Venook AP, Adam M, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: colon cancer, V3.2025. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. 
  • Rosenberg PS, Miranda-Filho A. Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw Open. 2024 Jun 3;7(6):e2415731. doi: 10.1001/jamanetworkopen.2024.15731. PMID: 38857048; PMCID: PMC11165384. 
  • Smeltzer MP, Wynes MW, Lantuejoul S, et al. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer. J Thorac Oncol. 2020 Sep;15(9):1434-1448. doi: 10.1016/j.jtho.2020.05.002.


The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice.


]]> Tue, 29 Apr 2025 16:14:12 -0400 https://www.primetherapeutics.com/ 50:55 In this episode, you’ll hear about the latest developments in tailoring cancer treatments to individual patients using Precision Oncology.  

Two thought leaders, Simone Ndujiuba, a Clinical Oncology Pharmacist at Prime Therapeutics, and Karan Cushman, Head of Brand Experience and host of The Precision Medicine Podcast for Trapelo Health, discuss real-world research that is paving the way for Prime and our partners to help providers reduce turnaround times so patients can start treatment as soon as possible.  Join your host Maryam Tabatabai as they dig into this evolving topic of precision oncology. 

www.primetherapeuitics.com 


⁠Chapters⁠

Defining precision medicine (08:50)

Evaluating real-world operational process of biomarker testing (14:36)

Turnaround times are crucial (17:40)

A patients view into the importance of time (24:39)

Technology and process aid in time and process (29:30)

Helping bridge knowledge gaps for providers and payers (33:55) 

The focus is on Precision Oncology right now (37:00)

Precision medicine in other disease categories (40:09)

Future of precision oncology is bright (42:07)

 

References 

  • Singh, B.P., et al. (2019). Molecular profiling (MP) for malignancies: Knowledge gaps and variable practice patterns among United States oncologists (Onc). 
    • American Society of Clinical Oncology. https://meetings. asco.org/abstracts-presentations/173392 
  • Evangelist, M.C., et al. (2023). Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study. Journal of Clinical Oncology, 41(Supplement 16). https://doi.org/10.1200/JCO.2023.41.16_suppl.9109. 
  • Ossowski, S., et al. (2022). Improving time to molecular testing results in patients with newly diagnosed, metastatic non-small cell lung cancer. Journal of Clinical Oncology, 18(11). https://doi.org/10.1200/OP.22.00260 
  • Naithani N, Atal AT, Tilak TVSVGK, et al. Precision medicine: Uses and challenges. Med J Armed Forces India. 2021 Jul;77(3):258-265. doi: 10.1016/j.mjafi.2021.06.020.  
  • Jørgensen JT. Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy. Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054.  
  • MedlinePlus. What is genetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/genetics/understanding/testing/genetictesting/. 
  • MedlinePlus. What is pharmacogenetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/lab-tests/pharmacogenetic-tests/#:~:text=Pharmacogenetics%20(also%20called%20pharmacogenomics)%20is,your%20height%20and%20eye%20color.  
  • Riely GJ, Wood DE, Aisner DL, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: non-small cell lung cancer, V3.2005. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.  
  • Benson AB, Venook AP, Adam M, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: colon cancer, V3.2025. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. 
  • Rosenberg PS, Miranda-Filho A. Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw Open. 2024 Jun 3;7(6):e2415731. doi: 10.1001/jamanetworkopen.2024.15731. PMID: 38857048; PMCID: PMC11165384. 
  • Smeltzer MP, Wynes MW, Lantuejoul S, et al. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer. J Thorac Oncol. 2020 Sep;15(9):1434-1448. doi: 10.1016/j.jtho.2020.05.002.


The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice.


]]> In this episode, you’ll hear about the latest developments in tailoring cancer treatments to individual patients using Precision Oncology.  

Two thought leaders, Simone Ndujiuba, a Clinical Oncology Pharmacist at Prime Therapeutics, and Karan Cushman, Head of Brand Experience and host of The Precision Medicine Podcast for Trapelo Health, discuss real-world research that is paving the way for Prime and our partners to help providers reduce turnaround times so patients can start treatment as soon as possible.  Join your host Maryam Tabatabai as they dig into this evolving topic of precision oncology. 

www.primetherapeuitics.com 


⁠Chapters⁠

Defining precision medicine (08:50)

Evaluating real-world operational process of biomarker testing (14:36)

Turnaround times are crucial (17:40)

A patients view into the importance of time (24:39)

Technology and process aid in time and process (29:30)

Helping bridge knowledge gaps for providers and payers (33:55) 

The focus is on Precision Oncology right now (37:00)

Precision medicine in other disease categories (40:09)

Future of precision oncology is bright (42:07)

 

References 

  • Singh, B.P., et al. (2019). Molecular profiling (MP) for malignancies: Knowledge gaps and variable practice patterns among United States oncologists (Onc). 
    • American Society of Clinical Oncology. https://meetings. asco.org/abstracts-presentations/173392 
  • Evangelist, M.C., et al. (2023). Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study. Journal of Clinical Oncology, 41(Supplement 16). https://doi.org/10.1200/JCO.2023.41.16_suppl.9109. 
  • Ossowski, S., et al. (2022). Improving time to molecular testing results in patients with newly diagnosed, metastatic non-small cell lung cancer. Journal of Clinical Oncology, 18(11). https://doi.org/10.1200/OP.22.00260 
  • Naithani N, Atal AT, Tilak TVSVGK, et al. Precision medicine: Uses and challenges. Med J Armed Forces India. 2021 Jul;77(3):258-265. doi: 10.1016/j.mjafi.2021.06.020.  
  • Jørgensen JT. Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy. Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054.  
  • MedlinePlus. What is genetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/genetics/understanding/testing/genetictesting/. 
  • MedlinePlus. What is pharmacogenetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/lab-tests/pharmacogenetic-tests/#:~:text=Pharmacogenetics%20(also%20called%20pharmacogenomics)%20is,your%20height%20and%20eye%20color.  
  • Riely GJ, Wood DE, Aisner DL, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: non-small cell lung cancer, V3.2005. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.  
  • Benson AB, Venook AP, Adam M, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: colon cancer, V3.2025. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. 
  • Rosenberg PS, Miranda-Filho A. Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw Open. 2024 Jun 3;7(6):e2415731. doi: 10.1001/jamanetworkopen.2024.15731. PMID: 38857048; PMCID: PMC11165384. 
  • Smeltzer MP, Wynes MW, Lantuejoul S, et al. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer. J Thorac Oncol. 2020 Sep;15(9):1434-1448. doi: 10.1016/j.jtho.2020.05.002.


The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice.


]]> false full <![CDATA[The research room – Decoding health outcomes (Part 2 -- On the road at AMCP Annual)]]> And here we are, at the Academy of Managed Care Pharmacy Annual for a 2nd year in row for a special “on the road” episode of Pharmacy Friends.  

This year, AMCP is in Houston with more than 6,000 managed care pharmacy and health care industry professionals in attendance. And thought leaders from Prime Therapeutics are also on hand to present 7 research posters and several education sessions based on our integrated medical and pharmacy claims data. 

This episode will help you gain clarity on the real-world impact of GLP-1 drugs, understand how predictive modeling can help identify members enrolled in Medicare Part D at risk of large increases in prescription drug spending, and other trends shaping the health care industry.

We also have two up and coming researchers share their experience taking their first steps in the managed care space and their careers. 


(00:00) Introduction

(01:05) 2024 JMCP “Article of the Year” Award for Excellence

(06:46) Latest GLP-1 research

(15:56) Accelerated Drug Approval Program

(28:00) PBM and Medical Pharmacy Industry Trends

(41:17) Medicare Member Drug Cost Predictive Model: Creation and Feature Engineering 

(50:32) Advancing Health Equity in Food Allergy Prevention and Treatment: Bridging Gaps in Care and Knowledge

(55:22) Legislative Impacts on Site of Service: What is the Big Deal?

(1:00:07) The next generation of managed care professionals

]]> Fri, 04 Apr 2025 16:14:12 -0400 https://www.primetherapeutics.com/ 1:15:24 And here we are, at the Academy of Managed Care Pharmacy Annual for a 2nd year in row for a special “on the road” episode of Pharmacy Friends.  

This year, AMCP is in Houston with more than 6,000 managed care pharmacy and health care industry professionals in attendance. And thought leaders from Prime Therapeutics are also on hand to present 7 research posters and several education sessions based on our integrated medical and pharmacy claims data. 

This episode will help you gain clarity on the real-world impact of GLP-1 drugs, understand how predictive modeling can help identify members enrolled in Medicare Part D at risk of large increases in prescription drug spending, and other trends shaping the health care industry.

We also have two up and coming researchers share their experience taking their first steps in the managed care space and their careers. 


(00:00) Introduction

(01:05) 2024 JMCP “Article of the Year” Award for Excellence

(06:46) Latest GLP-1 research

(15:56) Accelerated Drug Approval Program

(28:00) PBM and Medical Pharmacy Industry Trends

(41:17) Medicare Member Drug Cost Predictive Model: Creation and Feature Engineering 

(50:32) Advancing Health Equity in Food Allergy Prevention and Treatment: Bridging Gaps in Care and Knowledge

(55:22) Legislative Impacts on Site of Service: What is the Big Deal?

(1:00:07) The next generation of managed care professionals

]]> And here we are, at the Academy of Managed Care Pharmacy Annual for a 2nd year in row for a special “on the road” episode of Pharmacy Friends.  

This year, AMCP is in Houston with more than 6,000 managed care pharmacy and health care industry professionals in attendance. And thought leaders from Prime Therapeutics are also on hand to present 7 research posters and several education sessions based on our integrated medical and pharmacy claims data. 

This episode will help you gain clarity on the real-world impact of GLP-1 drugs, understand how predictive modeling can help identify members enrolled in Medicare Part D at risk of large increases in prescription drug spending, and other trends shaping the health care industry.

We also have two up and coming researchers share their experience taking their first steps in the managed care space and their careers. 


(00:00) Introduction

(01:05) 2024 JMCP “Article of the Year” Award for Excellence

(06:46) Latest GLP-1 research

(15:56) Accelerated Drug Approval Program

(28:00) PBM and Medical Pharmacy Industry Trends

(41:17) Medicare Member Drug Cost Predictive Model: Creation and Feature Engineering 

(50:32) Advancing Health Equity in Food Allergy Prevention and Treatment: Bridging Gaps in Care and Knowledge

(55:22) Legislative Impacts on Site of Service: What is the Big Deal?

(1:00:07) The next generation of managed care professionals

]]> false full <![CDATA[The research room – Decoding health outcomes (Part 1)]]> Managed care pharmacy is the practice of using real-world evidence to help patients get the right medications at the right cost. At Prime Therapeutics, the dedicated researchers who use studies to identify trends and recommend programs that improve overall health outcomes are members of the elite group called the health outcomes and research teams.  

Listen to explore Prime’s research room and hear from these experts about how they work so they can help Prime provide care like they would want for their loved ones.  

Be sure to follow Pharmacy Friends on your favorite podcast platform and tune in on April 4 to hear from more researchers as they dive into the data they are presenting at AMCP Annual.

]]> Mon, 17 Mar 2025 16:14:12 -0400 https://www.primetherapeutics.com/ 40:20 Managed care pharmacy is the practice of using real-world evidence to help patients get the right medications at the right cost. At Prime Therapeutics, the dedicated researchers who use studies to identify trends and recommend programs that improve overall health outcomes are members of the elite group called the health outcomes and research teams.  

Listen to explore Prime’s research room and hear from these experts about how they work so they can help Prime provide care like they would want for their loved ones.  

Be sure to follow Pharmacy Friends on your favorite podcast platform and tune in on April 4 to hear from more researchers as they dive into the data they are presenting at AMCP Annual.

]]> Managed care pharmacy is the practice of using real-world evidence to help patients get the right medications at the right cost. At Prime Therapeutics, the dedicated researchers who use studies to identify trends and recommend programs that improve overall health outcomes are members of the elite group called the health outcomes and research teams.  

Listen to explore Prime’s research room and hear from these experts about how they work so they can help Prime provide care like they would want for their loved ones.  

Be sure to follow Pharmacy Friends on your favorite podcast platform and tune in on April 4 to hear from more researchers as they dive into the data they are presenting at AMCP Annual.

]]> false full <![CDATA[Pharmacy in 2050]]> It’s not every day you get to listen to a conversation about health care artificial intelligence, 3D printed medicines and not so futuristic ways of simplifying not only the pharmacy experience but the entire health care industry. 

George Van Antwerp, industry veteran and Prime’s new SVP of product innovation, gives you insights into how he believes changes in consumerism is one of the leading reasons why he believes the health care industry needs to evolve. 

For more about George’s insights, read his Pharmacy in 2050 article published in the Journal of the American Pharmacists Association.


Pharmacy Friends episodes

www.primetherapeutics.com

More Prime Therapeutics news

]]> Tue, 18 Feb 2025 16:14:12 -0500 https://www.primetherapeutics.com/ 34:28 It’s not every day you get to listen to a conversation about health care artificial intelligence, 3D printed medicines and not so futuristic ways of simplifying not only the pharmacy experience but the entire health care industry. 

George Van Antwerp, industry veteran and Prime’s new SVP of product innovation, gives you insights into how he believes changes in consumerism is one of the leading reasons why he believes the health care industry needs to evolve. 

For more about George’s insights, read his Pharmacy in 2050 article published in the Journal of the American Pharmacists Association.


Pharmacy Friends episodes

www.primetherapeutics.com

More Prime Therapeutics news

]]> It’s not every day you get to listen to a conversation about health care artificial intelligence, 3D printed medicines and not so futuristic ways of simplifying not only the pharmacy experience but the entire health care industry. 

George Van Antwerp, industry veteran and Prime’s new SVP of product innovation, gives you insights into how he believes changes in consumerism is one of the leading reasons why he believes the health care industry needs to evolve. 

For more about George’s insights, read his Pharmacy in 2050 article published in the Journal of the American Pharmacists Association.


Pharmacy Friends episodes

www.primetherapeutics.com

More Prime Therapeutics news

]]> false full <![CDATA[Shielding against pharmacy deception]]> This episode uncovers what it’s like to investigate fraudulent pharmacies and why it matters for everyone involved. 


We have an impressive guest for you today. Our host Maryam Tabatabai, talks with Prime’s special investigation unit leader Mitchell Scott and right out of the gate he describes how he wanted to broaden his horizon to help people in ways he never thought of before. 


He gives you insight into how his SIU team at Prime works to protect clients, members and employees from people looking to take advantage of others through the health care system.


And that’s not it, he touches on how ALL of his team’s decisions are based on one simple thought, saving one life is all it takes for our actions to matter – and that is what they do best – providing the care they would want for their loved ones.


https://www.primetherapeutics.com

More Pharmacy Friends episodes


Prime’s Special Investigations Unit: A rockstar team


]]> Mon, 06 Jan 2025 16:14:12 -0500 https://www.primetherapeutics.com/ 30:54 This episode uncovers what it’s like to investigate fraudulent pharmacies and why it matters for everyone involved. 


We have an impressive guest for you today. Our host Maryam Tabatabai, talks with Prime’s special investigation unit leader Mitchell Scott and right out of the gate he describes how he wanted to broaden his horizon to help people in ways he never thought of before. 


He gives you insight into how his SIU team at Prime works to protect clients, members and employees from people looking to take advantage of others through the health care system.


And that’s not it, he touches on how ALL of his team’s decisions are based on one simple thought, saving one life is all it takes for our actions to matter – and that is what they do best – providing the care they would want for their loved ones.


https://www.primetherapeutics.com

More Pharmacy Friends episodes


Prime’s Special Investigations Unit: A rockstar team


]]> This episode uncovers what it’s like to investigate fraudulent pharmacies and why it matters for everyone involved. 


We have an impressive guest for you today. Our host Maryam Tabatabai, talks with Prime’s special investigation unit leader Mitchell Scott and right out of the gate he describes how he wanted to broaden his horizon to help people in ways he never thought of before. 


He gives you insight into how his SIU team at Prime works to protect clients, members and employees from people looking to take advantage of others through the health care system.


And that’s not it, he touches on how ALL of his team’s decisions are based on one simple thought, saving one life is all it takes for our actions to matter – and that is what they do best – providing the care they would want for their loved ones.


https://www.primetherapeutics.com

More Pharmacy Friends episodes


Prime’s Special Investigations Unit: A rockstar team


]]> false full <![CDATA[RSV: 'Tis the season for prevention]]> Dr. Scott Roberts, an infectious disease expert from Yale University, is back with us to share information about updated CDC guidelines for RSV vaccinations in a variety of populations. He also talks about how our nation’s health care systems seem to be much better equipped this RSV season. Finally, you’ll come away with a better understanding of what everyone can do to help prepare for this RSV season.

 

Pharmacy Friends Rewind: Last winter, we talked with Dr. Roberts about the new frontier of RSV vaccines. We chatted about access issues, along with RSV impact and risk factors for all populations. Give it a listen.

 

CDC: RSV information
www.primethrapeutics.com
All Pharmacy Friends episodes

 

Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> Tue, 17 Dec 2024 16:14:16 -0500 https://www.primetherapeutics.com/ 25:45 Dr. Scott Roberts, an infectious disease expert from Yale University, is back with us to share information about updated CDC guidelines for RSV vaccinations in a variety of populations. He also talks about how our nation’s health care systems seem to be much better equipped this RSV season. Finally, you’ll come away with a better understanding of what everyone can do to help prepare for this RSV season.

 

Pharmacy Friends Rewind: Last winter, we talked with Dr. Roberts about the new frontier of RSV vaccines. We chatted about access issues, along with RSV impact and risk factors for all populations. Give it a listen.

 

CDC: RSV information
www.primethrapeutics.com
All Pharmacy Friends episodes

 

Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> Dr. Scott Roberts, an infectious disease expert from Yale University, is back with us to share information about updated CDC guidelines for RSV vaccinations in a variety of populations. He also talks about how our nation’s health care systems seem to be much better equipped this RSV season. Finally, you’ll come away with a better understanding of what everyone can do to help prepare for this RSV season.

 

Pharmacy Friends Rewind: Last winter, we talked with Dr. Roberts about the new frontier of RSV vaccines. We chatted about access issues, along with RSV impact and risk factors for all populations. Give it a listen.

 

CDC: RSV information
www.primethrapeutics.com
All Pharmacy Friends episodes

 

Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

]]> false full <![CDATA[2024 Election special - Impact to the health care industry]]>

Millions of Americans took to voting booths to decide who will be the next president of the United States and here we are, the morning of Nov. 7, just two days after the historic election, to talk with two experts from the Prime Therapeutics government affairs team about the overall election and possible impact to our country’s health care system.


Host, Maryam Tabatabai, has a conversation with Caitlin Berry and Julie Cantor-Weinberg about the significance that these results may have in America’s history and how this election could impact the health care industry.


Our podcast

 "Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.

 

Ways to listen

⁠⁠⁠Amazon Music⁠⁠⁠ | ⁠⁠⁠Apple⁠⁠⁠ | ⁠⁠⁠Spotify⁠⁠⁠ | ⁠YouTube⁠

 

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.

 

Follow us on social: ⁠

⁠https://www.linkedin.com/company/prime-therapeutics/⁠⁠

⁠ ⁠https://www.youtube.com/user/PrimeTherapeutics⁠⁠

⁠ ⁠https://x.com/Prime_PBM⁠


]]> Thu, 07 Nov 2024 16:14:16 -0500 https://www.primetherapeutics.com/ 35:47

Millions of Americans took to voting booths to decide who will be the next president of the United States and here we are, the morning of Nov. 7, just two days after the historic election, to talk with two experts from the Prime Therapeutics government affairs team about the overall election and possible impact to our country’s health care system.


Host, Maryam Tabatabai, has a conversation with Caitlin Berry and Julie Cantor-Weinberg about the significance that these results may have in America’s history and how this election could impact the health care industry.


Our podcast

 "Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.

 

Ways to listen

⁠⁠⁠Amazon Music⁠⁠⁠ | ⁠⁠⁠Apple⁠⁠⁠ | ⁠⁠⁠Spotify⁠⁠⁠ | ⁠YouTube⁠

 

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.

 

Follow us on social: ⁠

⁠https://www.linkedin.com/company/prime-therapeutics/⁠⁠

⁠ ⁠https://www.youtube.com/user/PrimeTherapeutics⁠⁠

⁠ ⁠https://x.com/Prime_PBM⁠


]]>

Millions of Americans took to voting booths to decide who will be the next president of the United States and here we are, the morning of Nov. 7, just two days after the historic election, to talk with two experts from the Prime Therapeutics government affairs team about the overall election and possible impact to our country’s health care system.


Host, Maryam Tabatabai, has a conversation with Caitlin Berry and Julie Cantor-Weinberg about the significance that these results may have in America’s history and how this election could impact the health care industry.


Our podcast

 "Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.

 

Ways to listen

⁠⁠⁠Amazon Music⁠⁠⁠ | ⁠⁠⁠Apple⁠⁠⁠ | ⁠⁠⁠Spotify⁠⁠⁠ | ⁠YouTube⁠

 

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.

 

Follow us on social: ⁠

⁠https://www.linkedin.com/company/prime-therapeutics/⁠⁠

⁠ ⁠https://www.youtube.com/user/PrimeTherapeutics⁠⁠

⁠ ⁠https://x.com/Prime_PBM⁠


]]> false full <![CDATA[Pharmacists in focus: Voices of the profession]]> As we close out October and American Pharmacist Month, we have a special Power of People episode of Pharmacy Friends celebrating all pharmacists.

 

Hear from our host Laura Spitzack and three of Prime's bright pharmacists about how they see the expanding role that a licensed pharmacist can have in addressing public health challenges. From working with technology partners to leaning into giving back to the younger generation, you will hear how they are having a hand in reshaping patient care and improving health outcomes.


Our podcast

"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.

 

Ways to listen

⁠⁠Amazon Music⁠⁠ | ⁠⁠Apple⁠⁠ | ⁠⁠Spotify⁠⁠

 

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.

 

Follow us on social


https://www.linkedin.com/company/prime-therapeutics/⁠

⁠https://www.youtube.com/user/PrimeTherapeutics⁠

https://x.com/Prime_PBM

]]> Thu, 31 Oct 2024 16:14:16 -0400 https://www.primetherapeutics.com/ 25:53 As we close out October and American Pharmacist Month, we have a special Power of People episode of Pharmacy Friends celebrating all pharmacists.

 

Hear from our host Laura Spitzack and three of Prime's bright pharmacists about how they see the expanding role that a licensed pharmacist can have in addressing public health challenges. From working with technology partners to leaning into giving back to the younger generation, you will hear how they are having a hand in reshaping patient care and improving health outcomes.


Our podcast

"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.

 

Ways to listen

⁠⁠Amazon Music⁠⁠ | ⁠⁠Apple⁠⁠ | ⁠⁠Spotify⁠⁠

 

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.

 

Follow us on social


https://www.linkedin.com/company/prime-therapeutics/⁠

⁠https://www.youtube.com/user/PrimeTherapeutics⁠

https://x.com/Prime_PBM

]]> As we close out October and American Pharmacist Month, we have a special Power of People episode of Pharmacy Friends celebrating all pharmacists.

 

Hear from our host Laura Spitzack and three of Prime's bright pharmacists about how they see the expanding role that a licensed pharmacist can have in addressing public health challenges. From working with technology partners to leaning into giving back to the younger generation, you will hear how they are having a hand in reshaping patient care and improving health outcomes.


Our podcast

"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.

 

Ways to listen

⁠⁠Amazon Music⁠⁠ | ⁠⁠Apple⁠⁠ | ⁠⁠Spotify⁠⁠

 

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.

 

Follow us on social


https://www.linkedin.com/company/prime-therapeutics/⁠

⁠https://www.youtube.com/user/PrimeTherapeutics⁠

https://x.com/Prime_PBM

]]> false full <![CDATA[Prescription for change: The IRA’s impact on pharmacy]]> It’s been more than 2 years since the monumental Inflation Reduction Act bill passed. The bill offers opportunity for financial relief for millions of people with Medicare by improving access to affordable treatments.​ And today, we’re here to talk about how Prime is positioning ourselves to put people first and deliver flexible government health care programs that drive affordability and enhance the member experience.

 

Our host, Maryam Tabatabai, sits down with Prime's government programs and compliance experts Jason Moore and Angela Leroux for a conversation about the Inflation Reduction Act and why it's an important part of any government programs strategy. You’ll get a glimpse into Prime’s Center of Excellence, hear what Medicare members should be thinking about during open enrollment, and discover what health plans should expect in 2025 as the largest provisions go into effect.


All Pharmacy Friends episodes



More information:

https://www.primetherapeutics.com

https://www.primetherapeutics.com/medicare-and-managed-medicaid


About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn. 

]]> Wed, 30 Oct 2024 16:14:16 -0400 https://www.primetherapeutics.com/ 29:43 It’s been more than 2 years since the monumental Inflation Reduction Act bill passed. The bill offers opportunity for financial relief for millions of people with Medicare by improving access to affordable treatments.​ And today, we’re here to talk about how Prime is positioning ourselves to put people first and deliver flexible government health care programs that drive affordability and enhance the member experience.

 

Our host, Maryam Tabatabai, sits down with Prime's government programs and compliance experts Jason Moore and Angela Leroux for a conversation about the Inflation Reduction Act and why it's an important part of any government programs strategy. You’ll get a glimpse into Prime’s Center of Excellence, hear what Medicare members should be thinking about during open enrollment, and discover what health plans should expect in 2025 as the largest provisions go into effect.


All Pharmacy Friends episodes



More information:

https://www.primetherapeutics.com

https://www.primetherapeutics.com/medicare-and-managed-medicaid


About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn. 

]]> It’s been more than 2 years since the monumental Inflation Reduction Act bill passed. The bill offers opportunity for financial relief for millions of people with Medicare by improving access to affordable treatments.​ And today, we’re here to talk about how Prime is positioning ourselves to put people first and deliver flexible government health care programs that drive affordability and enhance the member experience.

 

Our host, Maryam Tabatabai, sits down with Prime's government programs and compliance experts Jason Moore and Angela Leroux for a conversation about the Inflation Reduction Act and why it's an important part of any government programs strategy. You’ll get a glimpse into Prime’s Center of Excellence, hear what Medicare members should be thinking about during open enrollment, and discover what health plans should expect in 2025 as the largest provisions go into effect.


All Pharmacy Friends episodes



More information:

https://www.primetherapeutics.com

https://www.primetherapeutics.com/medicare-and-managed-medicaid


About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn. 

]]> false full <![CDATA[Pt. 2 - Live at Specialty Summit ’24: Cell & gene therapy – The crossroads of sci-fi and reality]]> In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.

]]> Fri, 20 Sep 2024 16:14:23 -0400 https://www.primetherapeutics.com/ 8:17 In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.

]]> In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.

]]> false full <![CDATA[Full episode: Live at Specialty Summit ’24 – Connect. Elevate. Transform.]]> In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

Today, we’re talking with several leaders at Prime about how each is focusing their work on the three pieces of our newly formed framework. We want to help make medications more affordable, deliver an easy, transparent experience and, most importantly, help people achieve better health.

Pt. 1 – The specialty pharmacy shift – Reimagining for success

In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey.

As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.

Pt. 2 – Cell & gene therapy – The crossroads of sci-fi and reality

The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.

Pt. 3 – Health tech horizons – Diverse voices, unified innovation

In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.

]]> Fri, 20 Sep 2024 16:14:23 -0400 https://www.primetherapeutics.com/ 37:16 In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

Today, we’re talking with several leaders at Prime about how each is focusing their work on the three pieces of our newly formed framework. We want to help make medications more affordable, deliver an easy, transparent experience and, most importantly, help people achieve better health.

Pt. 1 – The specialty pharmacy shift – Reimagining for success

In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey.

As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.

Pt. 2 – Cell & gene therapy – The crossroads of sci-fi and reality

The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.

Pt. 3 – Health tech horizons – Diverse voices, unified innovation

In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.

]]> In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

Today, we’re talking with several leaders at Prime about how each is focusing their work on the three pieces of our newly formed framework. We want to help make medications more affordable, deliver an easy, transparent experience and, most importantly, help people achieve better health.

Pt. 1 – The specialty pharmacy shift – Reimagining for success

In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey.

As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.

Pt. 2 – Cell & gene therapy – The crossroads of sci-fi and reality

The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.

Pt. 3 – Health tech horizons – Diverse voices, unified innovation

In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.

]]> false full <![CDATA[Pt. 1 - Live at Specialty Summit ’24: The specialty pharmacy shift – Reimagining for success]]> In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey.

As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.

]]> Fri, 20 Sep 2024 16:14:23 -0400 https://www.primetherapeutics.com/ 11:44 In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey.

As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.

]]> In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey.

As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.

]]> false full <![CDATA[Pt. 3 - Live at Specialty Summit ’24: Health tech horizons – Diverse voices, unified innovation]]> In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.

]]> Fri, 20 Sep 2024 16:14:23 -0400 https://www.primetherapeutics.com/ 18:31 In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.

]]> In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.

In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.

]]> false full <![CDATA[Weight Management – A holistic journey ]]> GLP-1s and chronic weight management are two of the hottest topics in the medical industry. There isn’t nearly enough content devoted to weighing all the variables associated with them, which  our experts aim to address. 

In this episode of the Pharmacy Friends podcast, “Weight management – a holistic journey,” our experts discuss Prime’s four primary tenants of practice for chronic weight management and how they play a role in ensuring any recommendations are rooted in the evidence focusing on improving patient adherence and persistence to treatment and driving value.

Host, Maryam Tabatabai, vice president for clinical information at Prime Therapeutics, is joined by Pat Gleason PharmD, BCPS, FCCP, FAMCP, assistant vice president, health outcomes at Prime Therapeutics and Dariush Mozaffarian, M.D., Dr.P.H., Tufts University.


Developing a holistic GLP-1 strategy

Clinical Insights - Weight Management -- a holistic journey

All Pharmacy Friends episodes

]]> Wed, 31 Jul 2024 16:14:23 -0400 https://www.primetherapeutics.com/ 51:57 GLP-1s and chronic weight management are two of the hottest topics in the medical industry. There isn’t nearly enough content devoted to weighing all the variables associated with them, which  our experts aim to address. 

In this episode of the Pharmacy Friends podcast, “Weight management – a holistic journey,” our experts discuss Prime’s four primary tenants of practice for chronic weight management and how they play a role in ensuring any recommendations are rooted in the evidence focusing on improving patient adherence and persistence to treatment and driving value.

Host, Maryam Tabatabai, vice president for clinical information at Prime Therapeutics, is joined by Pat Gleason PharmD, BCPS, FCCP, FAMCP, assistant vice president, health outcomes at Prime Therapeutics and Dariush Mozaffarian, M.D., Dr.P.H., Tufts University.


Developing a holistic GLP-1 strategy

Clinical Insights - Weight Management -- a holistic journey

All Pharmacy Friends episodes

]]> GLP-1s and chronic weight management are two of the hottest topics in the medical industry. There isn’t nearly enough content devoted to weighing all the variables associated with them, which  our experts aim to address. 

In this episode of the Pharmacy Friends podcast, “Weight management – a holistic journey,” our experts discuss Prime’s four primary tenants of practice for chronic weight management and how they play a role in ensuring any recommendations are rooted in the evidence focusing on improving patient adherence and persistence to treatment and driving value.

Host, Maryam Tabatabai, vice president for clinical information at Prime Therapeutics, is joined by Pat Gleason PharmD, BCPS, FCCP, FAMCP, assistant vice president, health outcomes at Prime Therapeutics and Dariush Mozaffarian, M.D., Dr.P.H., Tufts University.


Developing a holistic GLP-1 strategy

Clinical Insights - Weight Management -- a holistic journey

All Pharmacy Friends episodes

]]> false full <![CDATA[Beyond the business – Stories of corporate kindness ]]> At Prime, we strive to provide the same care we would want for our loved ones. This purpose extends beyond our employees to encompass our members, clients and communities. 

In today’s Power of People edition of Pharmacy Friends, we talk about how our employees help goes beyond our work in health care. On any given day, Prime’s people can be found serving others in the communities where we live and work. 

Kerry Florian, vice president, total rewards, talks about Prime’s community giving program, PrimeCares, which brings employees together to donate, volunteer and participate in community events. 

She also talks about working with our communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger through the Prime Together Foundation.  

And today’s guest Becky DeRosia, senior development officer, Hennepin Healthcare Foundation, talks about their great purpose of healing and enriching life in our community and how organizations like the Prime Together Foundation are instrumental in their work. 

⁠Corporate social responsibility⁠

⁠PrimeCares⁠

⁠PrimeTogether Foundation⁠

⁠WATCH: PrimeTogether Foundation + Hennepin Healthcare Foundation ⁠+ ⁠Faith support for families experiencing trauma offers comfort, builds trust in health care system

]]> Mon, 15 Jul 2024 16:14:23 -0400 https://www.primetherapeutics.com/ 25:39 At Prime, we strive to provide the same care we would want for our loved ones. This purpose extends beyond our employees to encompass our members, clients and communities. 

In today’s Power of People edition of Pharmacy Friends, we talk about how our employees help goes beyond our work in health care. On any given day, Prime’s people can be found serving others in the communities where we live and work. 

Kerry Florian, vice president, total rewards, talks about Prime’s community giving program, PrimeCares, which brings employees together to donate, volunteer and participate in community events. 

She also talks about working with our communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger through the Prime Together Foundation.  

And today’s guest Becky DeRosia, senior development officer, Hennepin Healthcare Foundation, talks about their great purpose of healing and enriching life in our community and how organizations like the Prime Together Foundation are instrumental in their work. 

⁠Corporate social responsibility⁠

⁠PrimeCares⁠

⁠PrimeTogether Foundation⁠

⁠WATCH: PrimeTogether Foundation + Hennepin Healthcare Foundation ⁠+ ⁠Faith support for families experiencing trauma offers comfort, builds trust in health care system

]]> At Prime, we strive to provide the same care we would want for our loved ones. This purpose extends beyond our employees to encompass our members, clients and communities. 

In today’s Power of People edition of Pharmacy Friends, we talk about how our employees help goes beyond our work in health care. On any given day, Prime’s people can be found serving others in the communities where we live and work. 

Kerry Florian, vice president, total rewards, talks about Prime’s community giving program, PrimeCares, which brings employees together to donate, volunteer and participate in community events. 

She also talks about working with our communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger through the Prime Together Foundation.  

And today’s guest Becky DeRosia, senior development officer, Hennepin Healthcare Foundation, talks about their great purpose of healing and enriching life in our community and how organizations like the Prime Together Foundation are instrumental in their work. 

⁠Corporate social responsibility⁠

⁠PrimeCares⁠

⁠PrimeTogether Foundation⁠

⁠WATCH: PrimeTogether Foundation + Hennepin Healthcare Foundation ⁠+ ⁠Faith support for families experiencing trauma offers comfort, builds trust in health care system

]]> false full <![CDATA[Many voices, one purpose – Our 2023 Corporate Social Responsibility Report]]> A Power of People edition.

In today’s episode, Many Voices, One Purpose, you'll find out the true power of people and how Prime is an organization that continues to commit to diversity, equity and inclusion efforts.

Our host Laura Spitzack, talks with Zabrina Watkins, Melissa Strong and Pat Milligan, about how we unite through common values to find our path, keep growing and fundamentally strengthen our culture and the value we bring to all our partners and the communities we are privileged to serve.

You'll discover the true meaning behind "radical welcomeness," as they explore topics related to our DEI Council, Corporate Social responsibility and what’s on the horizon. You will also hear how we unite as one culture, with one purpose, and foster partnerships to collectively craft a better, more equitable and inclusive future for our employees and the people we serve.


2023 Corporate Social Responsibility Report

Our culture

Power of People video series

https://www.primetherapeutics.com/

]]> Fri, 10 May 2024 16:14:23 -0400 https://www.primetherapeutics.com/ 23:18 A Power of People edition.

In today’s episode, Many Voices, One Purpose, you'll find out the true power of people and how Prime is an organization that continues to commit to diversity, equity and inclusion efforts.

Our host Laura Spitzack, talks with Zabrina Watkins, Melissa Strong and Pat Milligan, about how we unite through common values to find our path, keep growing and fundamentally strengthen our culture and the value we bring to all our partners and the communities we are privileged to serve.

You'll discover the true meaning behind "radical welcomeness," as they explore topics related to our DEI Council, Corporate Social responsibility and what’s on the horizon. You will also hear how we unite as one culture, with one purpose, and foster partnerships to collectively craft a better, more equitable and inclusive future for our employees and the people we serve.


2023 Corporate Social Responsibility Report

Our culture

Power of People video series

https://www.primetherapeutics.com/

]]> A Power of People edition.

In today’s episode, Many Voices, One Purpose, you'll find out the true power of people and how Prime is an organization that continues to commit to diversity, equity and inclusion efforts.

Our host Laura Spitzack, talks with Zabrina Watkins, Melissa Strong and Pat Milligan, about how we unite through common values to find our path, keep growing and fundamentally strengthen our culture and the value we bring to all our partners and the communities we are privileged to serve.

You'll discover the true meaning behind "radical welcomeness," as they explore topics related to our DEI Council, Corporate Social responsibility and what’s on the horizon. You will also hear how we unite as one culture, with one purpose, and foster partnerships to collectively craft a better, more equitable and inclusive future for our employees and the people we serve.


2023 Corporate Social Responsibility Report

Our culture

Power of People video series

https://www.primetherapeutics.com/

]]> false full <![CDATA[Pt. 8 – Live at AMCP Annual 2024: Unlocking your pharmacy potential with our residency program]]> Nothing might matter more than getting new talented and bright pharmacists in our door to get hands-on experience of specialty and medical drug management from a managed care perspective. YuQian Liu, Senior Director of Clinical Account Services, talks about how our ASHP accredited residency program allows people interested in managed care pharmacy to build their careers. She talks about the importance of developing a firsthand understanding of medical and pharmacy benefit integration and strategy. And touches on the skills and mindset needed that helps kick-start careers as a managed care pharmacist. 

]]> Thu, 18 Apr 2024 16:14:33 -0400 https://www.primetherapeutics.com/ 7:13 Nothing might matter more than getting new talented and bright pharmacists in our door to get hands-on experience of specialty and medical drug management from a managed care perspective. YuQian Liu, Senior Director of Clinical Account Services, talks about how our ASHP accredited residency program allows people interested in managed care pharmacy to build their careers. She talks about the importance of developing a firsthand understanding of medical and pharmacy benefit integration and strategy. And touches on the skills and mindset needed that helps kick-start careers as a managed care pharmacist. 

]]> Nothing might matter more than getting new talented and bright pharmacists in our door to get hands-on experience of specialty and medical drug management from a managed care perspective. YuQian Liu, Senior Director of Clinical Account Services, talks about how our ASHP accredited residency program allows people interested in managed care pharmacy to build their careers. She talks about the importance of developing a firsthand understanding of medical and pharmacy benefit integration and strategy. And touches on the skills and mindset needed that helps kick-start careers as a managed care pharmacist. 

]]> false full <![CDATA[Pt. 7 – Live at AMCP Annual 2024: A look at specialty drug insights from the conference]]> The mission of the Academy of Managed Care Pharmacy is to enhance the quality and affordability of health care. Prime is likewise focused on this same mission, which is even more crucial when you consider a key category driving health care spend today are specialty drugs, which are typically injections or infusions that are self-administered or administered by health care professionals.  We caught up with Kristen Reimers, clinical pharmacist and senior vice president, Specialty Clinical Solutions at Prime, to talk about some of the education sessions at AMCP that touch on this important business segment.

]]> Thu, 18 Apr 2024 16:14:33 -0400 https://www.primetherapeutics.com/ 7:32 The mission of the Academy of Managed Care Pharmacy is to enhance the quality and affordability of health care. Prime is likewise focused on this same mission, which is even more crucial when you consider a key category driving health care spend today are specialty drugs, which are typically injections or infusions that are self-administered or administered by health care professionals.  We caught up with Kristen Reimers, clinical pharmacist and senior vice president, Specialty Clinical Solutions at Prime, to talk about some of the education sessions at AMCP that touch on this important business segment.

]]> The mission of the Academy of Managed Care Pharmacy is to enhance the quality and affordability of health care. Prime is likewise focused on this same mission, which is even more crucial when you consider a key category driving health care spend today are specialty drugs, which are typically injections or infusions that are self-administered or administered by health care professionals.  We caught up with Kristen Reimers, clinical pharmacist and senior vice president, Specialty Clinical Solutions at Prime, to talk about some of the education sessions at AMCP that touch on this important business segment.

]]> false full <![CDATA[Pt. 5 – Live at AMCP Annual 2024: Award-winning research shows how managed care pharmacists can aid individuals in transitioning to generic therapies]]> We’re about to hear about an award-winning research study. Recently, a number of generic multiple sclerosis medications supported by the American Academy of Neurology have become more widely available. Managed care pharmacists can aid individuals in transitioning to generic therapies, reducing total drug spend and member cost. But just how successful can this transition be? Prime researchers took a closer look, and Nick Friedlander, clinical program pharmacist with Prime, explains how transition may lead to remarkable savings and improved health outcomes.

]]> Thu, 18 Apr 2024 16:14:33 -0400 https://www.primetherapeutics.com/ 6:26 We’re about to hear about an award-winning research study. Recently, a number of generic multiple sclerosis medications supported by the American Academy of Neurology have become more widely available. Managed care pharmacists can aid individuals in transitioning to generic therapies, reducing total drug spend and member cost. But just how successful can this transition be? Prime researchers took a closer look, and Nick Friedlander, clinical program pharmacist with Prime, explains how transition may lead to remarkable savings and improved health outcomes.

]]> We’re about to hear about an award-winning research study. Recently, a number of generic multiple sclerosis medications supported by the American Academy of Neurology have become more widely available. Managed care pharmacists can aid individuals in transitioning to generic therapies, reducing total drug spend and member cost. But just how successful can this transition be? Prime researchers took a closer look, and Nick Friedlander, clinical program pharmacist with Prime, explains how transition may lead to remarkable savings and improved health outcomes.

]]> false full <![CDATA[Pt. 6 – Live at AMCP Annual 2024: Impact of a Medication Nonadherence Social Determinants of Health Risk Score]]> A key aspect of what AMCP seeks to achieve is improved access to care, and our next study looks closely at the factors that may impact that access. Social determinants of health are the conditions in a person’s environment that affect health, function, and quality-of-life outcomes and risks. These factors contribute to as much as 80% of variation in health outcomes. In this segment, Kyle Thompson, data scientist principal with Prime, talks about how the development of a Medicare member-specific medication nonadherence risk score, related to social determinants of health, can improve how a member manages medication and adheres to their doctors prescription. 

]]> Thu, 18 Apr 2024 16:14:33 -0400 https://www.primetherapeutics.com/ 5:38 A key aspect of what AMCP seeks to achieve is improved access to care, and our next study looks closely at the factors that may impact that access. Social determinants of health are the conditions in a person’s environment that affect health, function, and quality-of-life outcomes and risks. These factors contribute to as much as 80% of variation in health outcomes. In this segment, Kyle Thompson, data scientist principal with Prime, talks about how the development of a Medicare member-specific medication nonadherence risk score, related to social determinants of health, can improve how a member manages medication and adheres to their doctors prescription. 

]]> A key aspect of what AMCP seeks to achieve is improved access to care, and our next study looks closely at the factors that may impact that access. Social determinants of health are the conditions in a person’s environment that affect health, function, and quality-of-life outcomes and risks. These factors contribute to as much as 80% of variation in health outcomes. In this segment, Kyle Thompson, data scientist principal with Prime, talks about how the development of a Medicare member-specific medication nonadherence risk score, related to social determinants of health, can improve how a member manages medication and adheres to their doctors prescription. 

]]> false full <![CDATA[Pt. 4 – Live at AMCP Annual 2024: Medically integrated dispensing helps outcomes, lower waste and create better patient care experiences]]> Cancer care represents a rapidly rising and disproportionate share of overall health care spend. Medically integrated dispensing has been associated with better outcomes, lower waste and better patient care experiences for members receiving. Recognizing this value, payers have developed integrated dispensing networks to supplement traditional dispensing sites; however, little information is available comparing total cost of care. During this conversation with Landon Marshall, health outcomes research principal at Prime, we take a closer look at the AMCP study, Medically Integrated Dispensing of Oral Oncolytics: Real-World Cost of Care Comparison to Traditional Dispensing. 

]]> Thu, 18 Apr 2024 16:14:28 -0400 https://www.primetherapeutics.com/ 7:59 Cancer care represents a rapidly rising and disproportionate share of overall health care spend. Medically integrated dispensing has been associated with better outcomes, lower waste and better patient care experiences for members receiving. Recognizing this value, payers have developed integrated dispensing networks to supplement traditional dispensing sites; however, little information is available comparing total cost of care. During this conversation with Landon Marshall, health outcomes research principal at Prime, we take a closer look at the AMCP study, Medically Integrated Dispensing of Oral Oncolytics: Real-World Cost of Care Comparison to Traditional Dispensing. 

]]> Cancer care represents a rapidly rising and disproportionate share of overall health care spend. Medically integrated dispensing has been associated with better outcomes, lower waste and better patient care experiences for members receiving. Recognizing this value, payers have developed integrated dispensing networks to supplement traditional dispensing sites; however, little information is available comparing total cost of care. During this conversation with Landon Marshall, health outcomes research principal at Prime, we take a closer look at the AMCP study, Medically Integrated Dispensing of Oral Oncolytics: Real-World Cost of Care Comparison to Traditional Dispensing. 

]]> false full <![CDATA[Pt. 2 – Live at AMCP Annual 2024: A conversation with AMCP CEO Susan Cantrell]]> We are fortunate to have Susan Cantrell, AMCP CEO, join us for a conversation on what this show means and how it continues to have an impact on the health care industry. 

]]> Thu, 18 Apr 2024 16:14:28 -0400 https://www.primetherapeutics.com/ 17:03 We are fortunate to have Susan Cantrell, AMCP CEO, join us for a conversation on what this show means and how it continues to have an impact on the health care industry. 

]]> We are fortunate to have Susan Cantrell, AMCP CEO, join us for a conversation on what this show means and how it continues to have an impact on the health care industry. 

]]> false full <![CDATA[Pt. 3 – Live at AMCP Annual 2024: Ben Urick gives overview of GLP-1 data as it relates to weight loss.]]> Four of the Prime studies presented at AMCP relate to glucagon-like peptide-1 agonist – or GLP-1 – drugs. Earlier analysis of real-world data showed low adherence and increased cost of care for individuals in the first year of GLP-1 therapy. Prime has been a leader in GLP-1 insights, and three studies at AMCP take a fresh look at the GLP-1 data as it relates to weight loss. We have Ben Urick, Health Outcomes Reseach Senior Principal from Prime, here to walk us through the research.

]]> Thu, 18 Apr 2024 16:14:28 -0400 https://www.primetherapeutics.com/ 9:43 Four of the Prime studies presented at AMCP relate to glucagon-like peptide-1 agonist – or GLP-1 – drugs. Earlier analysis of real-world data showed low adherence and increased cost of care for individuals in the first year of GLP-1 therapy. Prime has been a leader in GLP-1 insights, and three studies at AMCP take a fresh look at the GLP-1 data as it relates to weight loss. We have Ben Urick, Health Outcomes Reseach Senior Principal from Prime, here to walk us through the research.

]]> Four of the Prime studies presented at AMCP relate to glucagon-like peptide-1 agonist – or GLP-1 – drugs. Earlier analysis of real-world data showed low adherence and increased cost of care for individuals in the first year of GLP-1 therapy. Prime has been a leader in GLP-1 insights, and three studies at AMCP take a fresh look at the GLP-1 data as it relates to weight loss. We have Ben Urick, Health Outcomes Reseach Senior Principal from Prime, here to walk us through the research.

]]> false full <![CDATA[Pt. 1 – Live at AMCP Annual 2024: Pat Gleason and David Eckwright share why Prime shows up at AMCP Annual]]> This year marks the second AMCP Annual meeting where Prime has showed up as one organization. But what does it mean for our business to show up at a crucial trade event like this? We are joined by two of our leaders responsible for putting our best foot forward at AMCP Annual, Pat Gleason, Assistant Vice President of Health Outcomes, and David Eckwright, Senior Director of Clinical Project and Program Management, to tell us more.  

]]> Thu, 18 Apr 2024 16:14:28 -0400 https://www.primetherapeutics.com/ 12:21 This year marks the second AMCP Annual meeting where Prime has showed up as one organization. But what does it mean for our business to show up at a crucial trade event like this? We are joined by two of our leaders responsible for putting our best foot forward at AMCP Annual, Pat Gleason, Assistant Vice President of Health Outcomes, and David Eckwright, Senior Director of Clinical Project and Program Management, to tell us more.  

]]> This year marks the second AMCP Annual meeting where Prime has showed up as one organization. But what does it mean for our business to show up at a crucial trade event like this? We are joined by two of our leaders responsible for putting our best foot forward at AMCP Annual, Pat Gleason, Assistant Vice President of Health Outcomes, and David Eckwright, Senior Director of Clinical Project and Program Management, to tell us more.  

]]> false full <![CDATA[FULL EPISODE: Live at AMCP Annual 2024 – Digging into managed care pharmacy insights]]> Jazz-laden melodies are typically the sonic output of “The Big Easy” but this week, it’s a special episode as we take you to the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, which was in New Orleans.

Leading researchers from Prime Therapeutics are at the show, and we talk with these health care experts from our Clinical and Health Outcomes teams who are using integrated medical and pharmacy claims data to evaluate real-world drug utilization, managed care pharmacy programs, and associated costs of care for a range of conditions, including weight loss, cardiovascular disease, cancer, and multiple sclerosis. 

And, in the spirit of our host city, we have a little fun with our guests and see how much they know about “The Big Easy.” 

We even had a drop in visit from Susan Cantrell, AMCP CEO, who talked with us about how AMCP is on the forefront of pharmacy trends, but also how the organization seeks to improve access to care and reduce costs, particularly as health care trends show that the pharmacy benefit is becoming more expensive. 

Dig into the research

All newsroom content

https://www.primetherapeutics.com/

Guests:  

  • Landon Marshall, principal, health outcomes research 

  • Ben Urick, senior principal, health outcomes research 

  • Yuqian Liu, senior director, clinical account services 

  • Kyle Thompson, principal, data scientist 

  • Nick Friedlander, clinical program pharmacist 

  • Pat Gleason, assistant vice president, health outcomes 

  • David Eckwright, senior director, clinical project and program management 

  • Kristen Reimers, senior vice president of specialty clinical solutions


     

]]> Thu, 18 Apr 2024 16:14:23 -0400 https://www.primetherapeutics.com/ 1:12:17 Jazz-laden melodies are typically the sonic output of “The Big Easy” but this week, it’s a special episode as we take you to the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, which was in New Orleans.

Leading researchers from Prime Therapeutics are at the show, and we talk with these health care experts from our Clinical and Health Outcomes teams who are using integrated medical and pharmacy claims data to evaluate real-world drug utilization, managed care pharmacy programs, and associated costs of care for a range of conditions, including weight loss, cardiovascular disease, cancer, and multiple sclerosis. 

And, in the spirit of our host city, we have a little fun with our guests and see how much they know about “The Big Easy.” 

We even had a drop in visit from Susan Cantrell, AMCP CEO, who talked with us about how AMCP is on the forefront of pharmacy trends, but also how the organization seeks to improve access to care and reduce costs, particularly as health care trends show that the pharmacy benefit is becoming more expensive. 

Dig into the research

All newsroom content

https://www.primetherapeutics.com/

Guests:  

  • Landon Marshall, principal, health outcomes research 

  • Ben Urick, senior principal, health outcomes research 

  • Yuqian Liu, senior director, clinical account services 

  • Kyle Thompson, principal, data scientist 

  • Nick Friedlander, clinical program pharmacist 

  • Pat Gleason, assistant vice president, health outcomes 

  • David Eckwright, senior director, clinical project and program management 

  • Kristen Reimers, senior vice president of specialty clinical solutions


     

]]> Jazz-laden melodies are typically the sonic output of “The Big Easy” but this week, it’s a special episode as we take you to the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, which was in New Orleans.

Leading researchers from Prime Therapeutics are at the show, and we talk with these health care experts from our Clinical and Health Outcomes teams who are using integrated medical and pharmacy claims data to evaluate real-world drug utilization, managed care pharmacy programs, and associated costs of care for a range of conditions, including weight loss, cardiovascular disease, cancer, and multiple sclerosis. 

And, in the spirit of our host city, we have a little fun with our guests and see how much they know about “The Big Easy.” 

We even had a drop in visit from Susan Cantrell, AMCP CEO, who talked with us about how AMCP is on the forefront of pharmacy trends, but also how the organization seeks to improve access to care and reduce costs, particularly as health care trends show that the pharmacy benefit is becoming more expensive. 

Dig into the research

All newsroom content

https://www.primetherapeutics.com/

Guests:  

  • Landon Marshall, principal, health outcomes research 

  • Ben Urick, senior principal, health outcomes research 

  • Yuqian Liu, senior director, clinical account services 

  • Kyle Thompson, principal, data scientist 

  • Nick Friedlander, clinical program pharmacist 

  • Pat Gleason, assistant vice president, health outcomes 

  • David Eckwright, senior director, clinical project and program management 

  • Kristen Reimers, senior vice president of specialty clinical solutions


     

]]> false full <![CDATA[Special edition! Revolutionizing Healthcare: Prime & Capital Rx's Game-Changing Alliance]]> In this special edition of Pharmacy Friends, Mostafa Kamal, Prime Therapeutics, President and CEO, joined Capital Rx’s Chief Executive Officer AJ Loiacono and SVP of Marketing & Communications Michael Passanante on the Astonishing Healthcare Podcast by Capital Rx.

They share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy and provide better care to patients across the country leveraging next-generation technology: JUDI®. 


Prime's Newsroom

www.primetherapeutics.com

All Pharmacy Friends episodes


Capital Rx podcasts

https://www.cap-rx.com/

]]> Fri, 05 Apr 2024 16:14:33 -0400 https://www.primetherapeutics.com/ 19:40 In this special edition of Pharmacy Friends, Mostafa Kamal, Prime Therapeutics, President and CEO, joined Capital Rx’s Chief Executive Officer AJ Loiacono and SVP of Marketing & Communications Michael Passanante on the Astonishing Healthcare Podcast by Capital Rx.

They share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy and provide better care to patients across the country leveraging next-generation technology: JUDI®. 


Prime's Newsroom

www.primetherapeutics.com

All Pharmacy Friends episodes


Capital Rx podcasts

https://www.cap-rx.com/

]]> In this special edition of Pharmacy Friends, Mostafa Kamal, Prime Therapeutics, President and CEO, joined Capital Rx’s Chief Executive Officer AJ Loiacono and SVP of Marketing & Communications Michael Passanante on the Astonishing Healthcare Podcast by Capital Rx.

They share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy and provide better care to patients across the country leveraging next-generation technology: JUDI®. 


Prime's Newsroom

www.primetherapeutics.com

All Pharmacy Friends episodes


Capital Rx podcasts

https://www.cap-rx.com/

]]> false full <![CDATA[The Skinny on GLP-1s: Part 2]]> Welcome to Pharmacy Friends – we bring industry experts to the same table to talk about what is happening in pharmacy today, what is coming, and most importantly, what it means to you.

A hot topic in the health care industry is GLP1s and chronic weight management. In this last segment of our two-part episode, our experts discuss Prime’s analysis of real-world integrated pharmacy and medical claims data. 

Hosting today’s episode “The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information. Joining her are two experts, David Lassen, a clinic pharmacist and Prime’s Chief Clinical Officer, who has strategic oversight of clinical services and support for customers. Pat Gleason, assistant vice president, leads Prime’s health outcomes team which performs deep dives into research data. These three experts discuss how their data shows low adherence and increased costs in the first year and how they hope to see additional data to refine our guidance on GLP1s and chronic weight management approaches.

The Skinny on GLP-1s: Part 1

Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year

All Pharmacy Friends episodes


https://www.primetherapeutics.com/

]]> Thu, 08 Feb 2024 16:14:41 -0500 https://www.primetherapeutics.com/ 38:07 Welcome to Pharmacy Friends – we bring industry experts to the same table to talk about what is happening in pharmacy today, what is coming, and most importantly, what it means to you.

A hot topic in the health care industry is GLP1s and chronic weight management. In this last segment of our two-part episode, our experts discuss Prime’s analysis of real-world integrated pharmacy and medical claims data. 

Hosting today’s episode “The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information. Joining her are two experts, David Lassen, a clinic pharmacist and Prime’s Chief Clinical Officer, who has strategic oversight of clinical services and support for customers. Pat Gleason, assistant vice president, leads Prime’s health outcomes team which performs deep dives into research data. These three experts discuss how their data shows low adherence and increased costs in the first year and how they hope to see additional data to refine our guidance on GLP1s and chronic weight management approaches.

The Skinny on GLP-1s: Part 1

Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year

All Pharmacy Friends episodes


https://www.primetherapeutics.com/

]]> Welcome to Pharmacy Friends – we bring industry experts to the same table to talk about what is happening in pharmacy today, what is coming, and most importantly, what it means to you.

A hot topic in the health care industry is GLP1s and chronic weight management. In this last segment of our two-part episode, our experts discuss Prime’s analysis of real-world integrated pharmacy and medical claims data. 

Hosting today’s episode “The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information. Joining her are two experts, David Lassen, a clinic pharmacist and Prime’s Chief Clinical Officer, who has strategic oversight of clinical services and support for customers. Pat Gleason, assistant vice president, leads Prime’s health outcomes team which performs deep dives into research data. These three experts discuss how their data shows low adherence and increased costs in the first year and how they hope to see additional data to refine our guidance on GLP1s and chronic weight management approaches.

The Skinny on GLP-1s: Part 1

Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year

All Pharmacy Friends episodes


https://www.primetherapeutics.com/

]]> false full <![CDATA[The Skinny on GLP-1s: Part 1 ]]>  A hot topic in the health care industry is GLP1s and chronic weight management. In this first of a two-part episode, our experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.  

Hosting The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information, and is joined are two experts, Olivia Pane, a clinical pharmacist at Prime, who is also a certified diabetes care and education specialist by helping manage and treat diabetes, weight gain and other chronic conditions. Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval.   

These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines. 

Check out our other GLP1 content

David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video

Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year ------------------------------------------------------------------

More about Prime

News and information



]]> Mon, 08 Jan 2024 16:14:41 -0500 https://www.primetherapeutics.com/ 43:13  A hot topic in the health care industry is GLP1s and chronic weight management. In this first of a two-part episode, our experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.  

Hosting The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information, and is joined are two experts, Olivia Pane, a clinical pharmacist at Prime, who is also a certified diabetes care and education specialist by helping manage and treat diabetes, weight gain and other chronic conditions. Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval.   

These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines. 

Check out our other GLP1 content

David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video

Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year ------------------------------------------------------------------

More about Prime

News and information



]]>  A hot topic in the health care industry is GLP1s and chronic weight management. In this first of a two-part episode, our experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.  

Hosting The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information, and is joined are two experts, Olivia Pane, a clinical pharmacist at Prime, who is also a certified diabetes care and education specialist by helping manage and treat diabetes, weight gain and other chronic conditions. Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval.   

These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines. 

Check out our other GLP1 content

David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video

Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year ------------------------------------------------------------------

More about Prime

News and information



]]> false full <![CDATA[Navigating the RSV Vaccine Frontier]]> In this episode, Navigating the RSV vaccine frontier, join Maryam Tabatabai, PharmD, a clinical information expert at Prime, as she talks about the new frontier of RSV monoclonal antibodies and vaccines with Scott Roberts, MD, an infectious disease expert from Yale University, who is navigating RSV season both professionally and personally. In this episode, these thought leaders discuss why RSV is a current hot topic in the health care industry and how it’s impacting both health care systems and patients who choose to get the vaccine. Listen to their discussion covering the CDC guidance on obtaining access, the impact and risk factors of the illness and vaccines in both pediatric and adult populations, along with some conversation about how RSV monoclonal antibodies and vaccines can be administered.  Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen. More about our company - https://www.primetherapeutics.com/

Newsroom - https://www.primetherapeutics.com/news/

Making pharmacy’s future brighter - https://www.primetherapeutics.com/about/reimagine-pharmacy/

Join Prime - https://www.primetherapeutics.com/careers/


]]> Tue, 05 Dec 2023 16:14:41 -0500 https://www.primetherapeutics.com/ 35:09 In this episode, Navigating the RSV vaccine frontier, join Maryam Tabatabai, PharmD, a clinical information expert at Prime, as she talks about the new frontier of RSV monoclonal antibodies and vaccines with Scott Roberts, MD, an infectious disease expert from Yale University, who is navigating RSV season both professionally and personally. In this episode, these thought leaders discuss why RSV is a current hot topic in the health care industry and how it’s impacting both health care systems and patients who choose to get the vaccine. Listen to their discussion covering the CDC guidance on obtaining access, the impact and risk factors of the illness and vaccines in both pediatric and adult populations, along with some conversation about how RSV monoclonal antibodies and vaccines can be administered.  Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen. More about our company - https://www.primetherapeutics.com/

Newsroom - https://www.primetherapeutics.com/news/

Making pharmacy’s future brighter - https://www.primetherapeutics.com/about/reimagine-pharmacy/

Join Prime - https://www.primetherapeutics.com/careers/


]]> In this episode, Navigating the RSV vaccine frontier, join Maryam Tabatabai, PharmD, a clinical information expert at Prime, as she talks about the new frontier of RSV monoclonal antibodies and vaccines with Scott Roberts, MD, an infectious disease expert from Yale University, who is navigating RSV season both professionally and personally. In this episode, these thought leaders discuss why RSV is a current hot topic in the health care industry and how it’s impacting both health care systems and patients who choose to get the vaccine. Listen to their discussion covering the CDC guidance on obtaining access, the impact and risk factors of the illness and vaccines in both pediatric and adult populations, along with some conversation about how RSV monoclonal antibodies and vaccines can be administered.  Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen. More about our company - https://www.primetherapeutics.com/

Newsroom - https://www.primetherapeutics.com/news/

Making pharmacy’s future brighter - https://www.primetherapeutics.com/about/reimagine-pharmacy/

Join Prime - https://www.primetherapeutics.com/careers/


]]> false full 1 2 <![CDATA[Oncology Xclusive]]> Discover how the brightest minds in oncology are illuminating the possibilities. Listen to Simone Ndujiuba, Oncology Clinical Strategy, and Innovation Director, and Dr. Joseph Leach Chief Medical Officer at Prime Therapeutics and Medical Oncologist at the University of Minnesota Physicians, join forces to discuss next-generation trends, cutting-edge technologies, and their captivating journey of becoming oncologists.

*Prime Therapeutics does not practice medicine.

]]> Mon, 20 Mar 2023 16:14:41 -0400 https://www.primetherapeutics.com/ 42:02 Discover how the brightest minds in oncology are illuminating the possibilities. Listen to Simone Ndujiuba, Oncology Clinical Strategy, and Innovation Director, and Dr. Joseph Leach Chief Medical Officer at Prime Therapeutics and Medical Oncologist at the University of Minnesota Physicians, join forces to discuss next-generation trends, cutting-edge technologies, and their captivating journey of becoming oncologists.

*Prime Therapeutics does not practice medicine.

]]> Discover how the brightest minds in oncology are illuminating the possibilities. Listen to Simone Ndujiuba, Oncology Clinical Strategy, and Innovation Director, and Dr. Joseph Leach Chief Medical Officer at Prime Therapeutics and Medical Oncologist at the University of Minnesota Physicians, join forces to discuss next-generation trends, cutting-edge technologies, and their captivating journey of becoming oncologists.

*Prime Therapeutics does not practice medicine.

]]> false full <![CDATA[A Deep Dive Into High-Cost Therapy]]> Hosted by Brian MacDonald, director of specialty clinical strategy at Prime, and joined by Kourteney Martinez, pharmacy engagement specialist at Blue Cross Blue Shield of Alabama.

]]> Tue, 17 Jan 2023 16:14:41 -0500 https://www.primetherapeutics.com/ 26:53 Hosted by Brian MacDonald, director of specialty clinical strategy at Prime, and joined by Kourteney Martinez, pharmacy engagement specialist at Blue Cross Blue Shield of Alabama.

]]> Hosted by Brian MacDonald, director of specialty clinical strategy at Prime, and joined by Kourteney Martinez, pharmacy engagement specialist at Blue Cross Blue Shield of Alabama.

]]> false full <![CDATA[American Pharmacists Month - Mark Santilli]]> Jonathan Magness, vice president of Medicare Part D operations sits down with Mark Santilli, senior director of clinical strategy and programs, to talk managed care, the future of pharmacy, and more!

]]> Thu, 10 Nov 2022 16:14:41 -0500 https://www.primetherapeutics.com/ 35:56 Jonathan Magness, vice president of Medicare Part D operations sits down with Mark Santilli, senior director of clinical strategy and programs, to talk managed care, the future of pharmacy, and more!

]]> Jonathan Magness, vice president of Medicare Part D operations sits down with Mark Santilli, senior director of clinical strategy and programs, to talk managed care, the future of pharmacy, and more!

]]> false full <![CDATA[American Pharmacists Month - Alaka'i Montalbo]]> Jonathan Magness, vice president of Medicare Part D operations sits down with Alaka'i Montalbo, senior manager of formulary management, to talk managed care, the future of pharmacy, and more!

]]> Mon, 10 Oct 2022 16:14:41 -0400 https://www.primetherapeutics.com/ 1:20 Jonathan Magness, vice president of Medicare Part D operations sits down with Alaka'i Montalbo, senior manager of formulary management, to talk managed care, the future of pharmacy, and more!

]]> Jonathan Magness, vice president of Medicare Part D operations sits down with Alaka'i Montalbo, senior manager of formulary management, to talk managed care, the future of pharmacy, and more!

]]> false full <![CDATA[Precision Medicine in Oncology ]]> The field of oncology is rapidly changing and evolving, with treatment becoming more precise and the speed of innovation compounding each year.

As more targeted therapies come to market, more patients have the hope of living a longer life. In this past record-setting year, more novel cancer medicines became available for the first time than in any year in history, and many of them employ immunology or precision biomarkers to transform the way patients are treated.

On this episode of Pharmacy Friends, we’re diving deep into precision medicine with Haita Makanji, Vice President of Clinical Strategy and Innovation at Prime, and Clynt Taylor, President of Trapelo. Trapelo offers the first, interoperable, decision-support platform used by oncologists, labs, and payers to inform testing and treatment, streamline workflow and facilitate real-time alignment in precision medicine.

Listen and learn how precision medicine be maximized to give cancer patients the best possible outcomes.

This episode is brought to you by the Prime Specialty Summit. After two years of virtual events, we're back in New York City, bringing you brilliant speakers, thought-provoking panels, in-person networking, and live music. Register now.

]]> Tue, 12 Jul 2022 16:14:44 -0400 https://www.primetherapeutics.com/ 34:49 The field of oncology is rapidly changing and evolving, with treatment becoming more precise and the speed of innovation compounding each year.

As more targeted therapies come to market, more patients have the hope of living a longer life. In this past record-setting year, more novel cancer medicines became available for the first time than in any year in history, and many of them employ immunology or precision biomarkers to transform the way patients are treated.

On this episode of Pharmacy Friends, we’re diving deep into precision medicine with Haita Makanji, Vice President of Clinical Strategy and Innovation at Prime, and Clynt Taylor, President of Trapelo. Trapelo offers the first, interoperable, decision-support platform used by oncologists, labs, and payers to inform testing and treatment, streamline workflow and facilitate real-time alignment in precision medicine.

Listen and learn how precision medicine be maximized to give cancer patients the best possible outcomes.

This episode is brought to you by the Prime Specialty Summit. After two years of virtual events, we're back in New York City, bringing you brilliant speakers, thought-provoking panels, in-person networking, and live music. Register now.

]]> The field of oncology is rapidly changing and evolving, with treatment becoming more precise and the speed of innovation compounding each year.

As more targeted therapies come to market, more patients have the hope of living a longer life. In this past record-setting year, more novel cancer medicines became available for the first time than in any year in history, and many of them employ immunology or precision biomarkers to transform the way patients are treated.

On this episode of Pharmacy Friends, we’re diving deep into precision medicine with Haita Makanji, Vice President of Clinical Strategy and Innovation at Prime, and Clynt Taylor, President of Trapelo. Trapelo offers the first, interoperable, decision-support platform used by oncologists, labs, and payers to inform testing and treatment, streamline workflow and facilitate real-time alignment in precision medicine.

Listen and learn how precision medicine be maximized to give cancer patients the best possible outcomes.

This episode is brought to you by the Prime Specialty Summit. After two years of virtual events, we're back in New York City, bringing you brilliant speakers, thought-provoking panels, in-person networking, and live music. Register now.

]]> false full 6 1 <![CDATA[Together, We Can Prevent Diabetes ]]> Millions of Americans are diagnosed with Type 2 diabetes, a serious and expensive health condition.

In this episode of Pharmacy Friends, Prime Medical Director, Dr. Marci Chodroff, moderates an engaging discussion on all things diabetes and the key to improving patient health and reducing healthcare costs. Joining Dr. Chodroff is Barb Corn, Vice President of Physician and Clinical Operations, and Dr. Arpeta Gupta, endocrinologist expert and Magellan Rx Physician Clinical Reviewer. 

If you would like to learn more about the CDC National Diabetes Prevention Program, check out these resources: 

]]> Fri, 08 Jul 2022 16:14:41 -0400 https://www.primetherapeutics.com/ 34:21 Millions of Americans are diagnosed with Type 2 diabetes, a serious and expensive health condition.

In this episode of Pharmacy Friends, Prime Medical Director, Dr. Marci Chodroff, moderates an engaging discussion on all things diabetes and the key to improving patient health and reducing healthcare costs. Joining Dr. Chodroff is Barb Corn, Vice President of Physician and Clinical Operations, and Dr. Arpeta Gupta, endocrinologist expert and Magellan Rx Physician Clinical Reviewer. 

If you would like to learn more about the CDC National Diabetes Prevention Program, check out these resources: 

]]> Millions of Americans are diagnosed with Type 2 diabetes, a serious and expensive health condition.

In this episode of Pharmacy Friends, Prime Medical Director, Dr. Marci Chodroff, moderates an engaging discussion on all things diabetes and the key to improving patient health and reducing healthcare costs. Joining Dr. Chodroff is Barb Corn, Vice President of Physician and Clinical Operations, and Dr. Arpeta Gupta, endocrinologist expert and Magellan Rx Physician Clinical Reviewer. 

If you would like to learn more about the CDC National Diabetes Prevention Program, check out these resources: 

]]> false full 7 1 <![CDATA[It Pays to be Healthy]]> Ever wonder how you can truly motivate people to change their habits? How to get someone who would never take their medication to finally follow through with it? In this episode, we are bringing you an in-depth exploration of behavioral economics and how healthcare is transforming through technology. Sagar Makanji, Vice President of Clinical Strategy and Programs at Prime, is joined by Matt Loper, CEO, and Co-founder of Wellth. They dive into leveraging the science of behavioral economics to help people form new healthy habits and create lasting behavior change. 

Grab some tissues and check out the video they mention in the episode here: https://vimeo.com/654346180/24c1585f3a

]]> Wed, 01 Jun 2022 16:14:44 -0400 https://www.primetherapeutics.com/ 1:07:55 Ever wonder how you can truly motivate people to change their habits? How to get someone who would never take their medication to finally follow through with it? In this episode, we are bringing you an in-depth exploration of behavioral economics and how healthcare is transforming through technology. Sagar Makanji, Vice President of Clinical Strategy and Programs at Prime, is joined by Matt Loper, CEO, and Co-founder of Wellth. They dive into leveraging the science of behavioral economics to help people form new healthy habits and create lasting behavior change. 

Grab some tissues and check out the video they mention in the episode here: https://vimeo.com/654346180/24c1585f3a

]]> Ever wonder how you can truly motivate people to change their habits? How to get someone who would never take their medication to finally follow through with it? In this episode, we are bringing you an in-depth exploration of behavioral economics and how healthcare is transforming through technology. Sagar Makanji, Vice President of Clinical Strategy and Programs at Prime, is joined by Matt Loper, CEO, and Co-founder of Wellth. They dive into leveraging the science of behavioral economics to help people form new healthy habits and create lasting behavior change. 

Grab some tissues and check out the video they mention in the episode here: https://vimeo.com/654346180/24c1585f3a

]]> false full 5 1 <![CDATA[What is 340B? ]]> We are diving into all things 340B on this episode. Julie Burns, our resident consultant healthcare whiz is joined by Kevin Denton, a certified 340B expert and pharmacy programs mastermind at Prime. Listen to this episode to learn about 340B and hear some fun, facts, and mythbusters.

]]> Thu, 16 Dec 2021 16:14:44 -0500 https://www.primetherapeutics.com/ 19:03 We are diving into all things 340B on this episode. Julie Burns, our resident consultant healthcare whiz is joined by Kevin Denton, a certified 340B expert and pharmacy programs mastermind at Prime. Listen to this episode to learn about 340B and hear some fun, facts, and mythbusters.

]]> We are diving into all things 340B on this episode. Julie Burns, our resident consultant healthcare whiz is joined by Kevin Denton, a certified 340B expert and pharmacy programs mastermind at Prime. Listen to this episode to learn about 340B and hear some fun, facts, and mythbusters.

]]> false full 4 1 <![CDATA[A Prescription for Loneliness ]]> Our latest Pharmacy Friends podcast episode is all about the “intangibles” (emotions & feelings) that have an impact on our overall health… and what we can do to address them for better outcomes.

Listen to Prime Expert, Brian MacDonald, and Eden Brownell of mPulse Mobile discuss the impact of digital tools on patient wellbeing and adherence.

]]> Thu, 09 Dec 2021 16:14:47 -0500 https://www.primetherapeutics.com/ 40:35 Our latest Pharmacy Friends podcast episode is all about the “intangibles” (emotions & feelings) that have an impact on our overall health… and what we can do to address them for better outcomes.

Listen to Prime Expert, Brian MacDonald, and Eden Brownell of mPulse Mobile discuss the impact of digital tools on patient wellbeing and adherence.

]]> Our latest Pharmacy Friends podcast episode is all about the “intangibles” (emotions & feelings) that have an impact on our overall health… and what we can do to address them for better outcomes.

Listen to Prime Expert, Brian MacDonald, and Eden Brownell of mPulse Mobile discuss the impact of digital tools on patient wellbeing and adherence.

]]> false full 3 1 <![CDATA[Medicare Open Enrollment Tips with Ms. Medicare ]]> It's Medicare Open Enrollment Season! Michelle Juhanson (aka Ms. Medicare) shares some tips for anyone aging into Medicare, enrolling in a new plan, or even staying with a current plan. Check out these resources discussed in the episode:

Medicare Resources
2022 "Medicare & You Handbook  
Preview 2022 Health & Prescription Drug Plans

]]> Sun, 21 Nov 2021 16:14:47 -0500 https://www.primetherapeutics.com/ 6:24 It's Medicare Open Enrollment Season! Michelle Juhanson (aka Ms. Medicare) shares some tips for anyone aging into Medicare, enrolling in a new plan, or even staying with a current plan. Check out these resources discussed in the episode:

Medicare Resources
2022 "Medicare & You Handbook  
Preview 2022 Health & Prescription Drug Plans

]]> It's Medicare Open Enrollment Season! Michelle Juhanson (aka Ms. Medicare) shares some tips for anyone aging into Medicare, enrolling in a new plan, or even staying with a current plan. Check out these resources discussed in the episode:

Medicare Resources
2022 "Medicare & You Handbook  
Preview 2022 Health & Prescription Drug Plans

]]> false full 2 1 <![CDATA[Customer Experience Lessons on #CXDay ]]> In the first episode of Pharmacy Friends, two Prime powerhouses, Meredith Delk and Stephanie Stevens, discuss all things customer experience,  employee engagement, and leadership, including lessons learned and key takeaways that you don’t want to miss. 

]]> Thu, 04 Nov 2021 16:14:47 -0400 https://www.primetherapeutics.com/ 54:00 In the first episode of Pharmacy Friends, two Prime powerhouses, Meredith Delk and Stephanie Stevens, discuss all things customer experience,  employee engagement, and leadership, including lessons learned and key takeaways that you don’t want to miss. 

]]> In the first episode of Pharmacy Friends, two Prime powerhouses, Meredith Delk and Stephanie Stevens, discuss all things customer experience,  employee engagement, and leadership, including lessons learned and key takeaways that you don’t want to miss. 

]]> false full 1 1 <![CDATA[Welcome to Pharmacy Friends]]> Pharmacy Friends Podcast is coming soon! 

]]> Tue, 28 Sep 2021 16:14:51 -0400 https://www.primetherapeutics.com/ 41 Pharmacy Friends Podcast is coming soon! 

]]> Pharmacy Friends Podcast is coming soon! 

]]> false trailer 1